Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

<!DOCTYPE html> <html lang="en" > <head > <meta charset="UTF-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="HandheldFriendly" content="True" /> <meta name="MobileOptimized" content="320" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="stylesheet" href="/static/assets/style-70b9163a.css" /> <script type="module" crossorigin="" src="/static/assets/base_style-ec2bc71e.js"></script> <link rel="stylesheet" href="/static/assets/style-ef962842.css" /> <link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" /> <script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script> <style> @media screen and (min-width: 64em) { div.pmc-wm { background: repeat-y; background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E"); padding-left: 3rem; } } </style> <link rel="apple-touch-icon" sizes="180x180" href="/static/img/favicons/apple-touch-icon.png" /> <link rel="icon" type="image/png" sizes="48x48" href="/static/img/favicons/favicon-48x48.png" /> <link rel="icon" type="image/png" sizes="32x32" href="/static/img/favicons/favicon-32x32.png" /> <link rel="icon" type="image/png" sizes="16x16" href="/static/img/favicons/favicon-16x16.png" /> <link rel="manifest" href="/static/img/favicons/site.webmanifest" /> <link rel="mask-icon" href="/static/img/favicons/safari-pinned-tab.svg" color="#0071bc" /> <meta name="msapplication-config" content="/static/img/favicons/browserconfig.xml" /> <meta name="theme-color" content="#ffffff" /> <title> Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - PMC </title>  <meta name="ncbi_app" content="cloudpmc-viewer" /> <meta name="ncbi_db" content="pmc" /> <meta name="ncbi_phid" content="6E4B6708741F2CB3036708003E6AD665.m_1" />  <meta name="ncbi_pdid" content="article" /> <link rel="preconnect" href="https://www.google-analytics.com" /> <link rel="dns-prefetch" href="https://cdn.ncbi.nlm.nih.gov" /> <link rel="preconnect" href="https://code.jquery.com" /> <meta name="ncbi_domain" content="elsevierwt"> <meta name="ncbi_type" content="fulltext"> <meta name="ncbi_pcid" content="journal"> <meta name="ncbi_feature" content="associated_data"> <link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/"> <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"> <meta name="citation_journal_title" content="Lancet (London, England)"> <meta name="citation_title" content="Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study"> <meta name="citation_author" content="Eleftheria Vasileiou"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Colin R Simpson"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author_institution" content="School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand"> <meta name="citation_author" content="Ting Shi"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Steven Kerr"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Utkarsh Agrawal"> <meta name="citation_author_institution" content="School of Medicine, University of St Andrews, St Andrews, UK"> <meta name="citation_author" content="Ashley Akbari"> <meta name="citation_author_institution" content="Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK"> <meta name="citation_author" content="Stuart Bedston"> <meta name="citation_author_institution" content="Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK"> <meta name="citation_author" content="Jillian Beggs"> <meta name="citation_author_institution" content="The Health Data Research Hub for Respiratory Health, Edinburgh, UK"> <meta name="citation_author" content="Declan Bradley"> <meta name="citation_author_institution" content="Public Health Agency, Belfast, UK"> <meta name="citation_author_institution" content="Centre for Public Health, Queen's University Belfast, Belfast, UK"> <meta name="citation_author" content="Antony Chuter"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author_institution" content="The Health Data Research Hub for Respiratory Health, Edinburgh, UK"> <meta name="citation_author" content="Simon de Lusignan"> <meta name="citation_author_institution" content="Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"> <meta name="citation_author" content="Annemarie B Docherty"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="David Ford"> <meta name="citation_author_institution" content="Health Informatics, Health Informatics Group, College of Medicine, Swansea University, Swansea, UK"> <meta name="citation_author" content="FD Richard Hobbs"> <meta name="citation_author_institution" content="Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"> <meta name="citation_author" content="Mark Joy"> <meta name="citation_author_institution" content="Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"> <meta name="citation_author" content="Srinivasa Vittal Katikireddi"> <meta name="citation_author_institution" content="MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK"> <meta name="citation_author" content="James Marple"> <meta name="citation_author_institution" content="Royal Infirmary of Edinburgh, NHS Lothian and Anaesthesia, Critical Care and Pain Medicine, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Colin McCowan"> <meta name="citation_author_institution" content="School of Medicine, University of St Andrews, St Andrews, UK"> <meta name="citation_author" content="Dylan McGagh"> <meta name="citation_author_institution" content="Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"> <meta name="citation_author" content="Jim McMenamin"> <meta name="citation_author_institution" content="Public Health Scotland, Glasgow UK"> <meta name="citation_author" content="Emily Moore"> <meta name="citation_author_institution" content="Public Health Scotland, Glasgow UK"> <meta name="citation_author" content="Josephine LK Murray"> <meta name="citation_author_institution" content="Public Health Scotland, Glasgow UK"> <meta name="citation_author" content="Jiafeng Pan"> <meta name="citation_author_institution" content="Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK"> <meta name="citation_author" content="Lewis Ritchie"> <meta name="citation_author_institution" content="Academic Primary Care, University of Aberdeen School of Medicine and Dentistry, Aberdeen, UK"> <meta name="citation_author" content="Syed Ahmar Shah"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Sarah Stock"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Fatemeh Torabi"> <meta name="citation_author_institution" content="Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK"> <meta name="citation_author" content="Ruby SM Tsang"> <meta name="citation_author_institution" content="Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"> <meta name="citation_author" content="Rachael Wood"> <meta name="citation_author_institution" content="Clinical and Public Health Intelligence team, Public Health Scotland, Edinburgh, UK"> <meta name="citation_author" content="Mark Woolhouse"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_author" content="Chris Robertson"> <meta name="citation_author_institution" content="Public Health Scotland, Glasgow UK"> <meta name="citation_author_institution" content="Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK"> <meta name="citation_author" content="Aziz Sheikh"> <meta name="citation_author_institution" content="Usher Institute, The University of Edinburgh, Edinburgh, UK"> <meta name="citation_publication_date" content="2021 May 1"> <meta name="citation_volume" content="397"> <meta name="citation_issue" content="10285"> <meta name="citation_firstpage" content="1646"> <meta name="citation_doi" content="10.1016/S0140-6736(21)00677-2"> <meta name="citation_pmid" content="33901420"> <meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/"> <meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/"> <meta name="description" content="The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other ..."> <meta name="og:title" content="Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study"> <meta name="og:type" content="article"> <meta name="og:site_name" content="PubMed Central (PMC)"> <meta name="og:description" content="The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other ..."> <meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/"> <meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@ncbi"> </head> <body > <a class="usa-skipnav " href="#main-content"> Skip to main content </a> <section class="usa-banner " aria-label="Official website of the United States government" > <div class="usa-accordion"> <header class="usa-banner__header"> <div class="usa-banner__inner"> <div class="grid-col-auto"> <img aria-hidden="true" class="usa-banner__header-flag" src="/static/img/us_flag.svg" alt="" /> </div> <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true"> <p class="usa-banner__header-text"> An official website of the United States government </p> <span class="usa-banner__header-action">Here's how you know</span> </div> <button type="button" class="usa-accordion__button usa-banner__button " aria-expanded="false" aria-controls="gov-banner-default" data-testid="storybook-django-banner" > <span class="usa-banner__button-text">Here's how you know</span> </button> </div> </header> <div class="usa-banner__content usa-accordion__content" id="gov-banner-default" hidden> <div class="grid-row grid-gap-lg"> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-dot-gov.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Official websites use .gov</strong> <br /> A <strong>.gov</strong> website belongs to an official government organization in the United States. </p> </div> </div> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-https.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Secure .gov websites use HTTPS</strong> <br /> A <strong>lock</strong> ( <span class="icon-lock"> <svg xmlns="http://www.w3.org/2000/svg" width="52" height="64" viewBox="0 0 52 64" class="usa-banner__lock-image" role="graphics-symbol" aria-labelledby="banner-lock-description" focusable="false"> <title id="banner-lock-title">Lock</title> <desc id="banner-lock-description"> Locked padlock icon </desc> <path fill="#000000" fill-rule="evenodd" d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" /> </svg> </span>) or <strong>https://</strong> means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. </p> </div> </div> </div> </div> </div> </section> <div class="usa-overlay"> </div> <header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header > <div class="ncbi-header"> <div class="ncbi-header__container"> <a class="ncbi-header__logo-container" href="/"> <img alt=" PMC home page " class="ncbi-header__logo-image" src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" /> </a>  <button type="button" class="usa-menu-btn ncbi-header__hamburger-button " aria-label="Show menu" data-testid="navMenuButton" > <svg aria-hidden="true" class="ncbi-hamburger-icon" fill="none" focusable="false" height="21" viewBox="0 0 31 21" width="31" xmlns="http://www.w3.org/2000/svg"> <path clip-rule="evenodd" d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z" fill="#F1F1F1" fill-rule="evenodd" /> </svg> </button>  <div class="ncbi-header__desktop-buttons">  <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button " aria-expanded="false" aria-controls="search-field-desktop-navigation" aria-label="Show search overlay" data-testid="toggleSearchPanelButton" data-toggle-search-panel-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#search" /> </svg> Search </button>  <div class="ncbi-header__login-dropdown"> <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button " aria-expanded="false" aria-controls="login-dropdown-menu" aria-label="Show login menu" data-testid="toggleLoginMenuDropdown" data-desktop-login-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#person" /> </svg> <span data-login-dropdown-text>Log in</span>  <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow> <use xlink:href="/static/img/sprite.svg#expand_less" /> </svg>  <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow> <use xlink:href="/static/img/sprite.svg#expand_more" /> </svg> </button>  <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu" id="login-dropdown-menu" data-desktop-login-menu-dropdown hidden> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__submenu-item">  <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> <li class="usa-nav__submenu-item"> <button type="button" class="usa-button usa-button--outline ncbi-header__login-dropdown-logout-button " data-testid="desktopLogoutButton" data-desktop-logout-button > Log out </button> </li> </ul> </div> </div> </div> </div>  <div class="ncbi-search-panel ncbi--show-only-at-desktop" data-testid="searchPanel" data-header-search-panel hidden> <div class="ncbi-search-panel__container"> <form action="https://www.ncbi.nlm.nih.gov/search/all/" aria-describedby="search-field-desktop-navigation-help-text" autocomplete="off" class="usa-search usa-search--big ncbi-search-panel__form" data-testid="form" method="GET" role="search"> <label class="usa-sr-only" data-testid="label" for="search-field-desktop-navigation"> Search… </label> <input class="usa-input" data-testid="textInput" id="search-field-desktop-navigation" name="term" placeholder="Search NCBI" type="search" value="" /> <button type="submit" class="usa-button " data-testid="button" > <span class="usa-search__submit-text"> Search NCBI </span> </button> </form> </div> </div> <nav aria-label="Primary navigation" class="usa-nav"> <p class="usa-sr-only" id="primary-navigation-sr-only-title"> Primary site navigation </p>  <button type="button" class="usa-nav__close ncbi-nav__close-button " aria-label="Close navigation menu" data-testid="navCloseButton" > <img src="/static/img/usa-icons/close.svg" alt="Close" /> </button>  <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6" role="search"> <label class="usa-sr-only" for="search-field"> Search </label> <input class="usa-input" id="search-field-mobile-navigation" type="search" placeholder="Search NCBI" name="search" /> <button type="submit" class="usa-button " >  <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==" class="usa-search__submit-icon" alt="Search" /> </button> </form>   <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop" data-mobile-login-menu hidden> <p class="ncbi-nav__mobile-login-menu-status"> Logged in as: <strong class="ncbi-nav__mobile-login-menu-email" data-mobile-login-email-text></strong> </p> <ul class="usa-nav__primary usa-accordion"> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> </ul> </div> <button type="button" class="usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop " data-testid="mobileLoginButton" data-mobile-login-button > Log in </button> </nav> </header> <section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box"> <div class="pmc-nav-container"> <div class="pmc-header__bar"> <div class="pmc-header__logo"> <a href="/" title="Home" aria-label="PMC Home"></a> </div> <button type="button" class="usa-button usa-button--unstyled pmc-header__search__button" aria-label="Open search" data-ga-category="search" data-ga-action="PMC" data-ga-label="pmc_search_panel_mobile" > <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#search"></use> </svg> <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="pmc-header__search"> <form class="usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form" autocomplete="off" role="search"> <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label> <span class="autoComplete_wrapper flex-1"> <input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search" type="search" name="term" data-autocomplete-url="/search/autocomplete/"/> </span> <button class="usa-button" type="submit" formaction="https://www.ncbi.nlm.nih.gov/pmc/" data-ga-category="search" data-ga-action="PMC" data-ga-label="PMC_search_button" > <span class="usa-search__submit-text">Search in PMC</span> <img src="/static/img/usa-icons-bg/search--white.svg" class="usa-search__submit-icon" alt="Search" /> </button> </form> <ul class="pmc-header__search__menu"> <li> <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search"> Advanced Search </a> </li> <li> <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list"> Journal List </a> </li> <li> <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link" data-ga-label="user guide"> User Guide </a> </li> </ul> </div> </div> </section> <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8064669"> <div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary"> <div class="grid-row"> <div class="grid-col-fill display-flex"> <div class="display-flex"> <ul class="usa-list usa-list--unstyled usa-list--horizontal"> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open resources" data-extra-class="is-visible-resources" data-ga-category="resources_accordion" data-ga-action="click" data-ga-label="mobile_icon" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#more_vert"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <a href="https://doi.org/10.1016/S0140-6736(21)00677-2" class="usa-link display-flex" role="button" target="_blank" rel="noreferrer noopener" aria-label="View on publisher site" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#launch"></use> </svg> </a> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button class="usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_mobile" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8064669%2F%23open-collections-dialog" data-in-collections="false" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button role="button" class="usa-button usa-button--unstyled citation-dialog-trigger display-flex" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_mobile" data-all-citations-url="/resources/citations/8064669/" data-citation-style="nlm" data-download-format-link="/resources/citations/8064669/export/" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> </button> </li> <li class="pmc-permalink display-flex"> <button type="button" class="usa-button usa-button--unstyled display-flex" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </div> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open article navigation" data-extra-class="is-visible-in-page" data-ga-category="actions" data-ga-action="open" data-ga-label="article_nav_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#list"></use> </svg> </button> </div> </div> </div> <div class="grid-container desktop:padding-left-6"> <div id="article-container" class="grid-row grid-gap"> <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content"> <div class="grid-container padding-left-0 padding-right-0"> <div class="grid-row desktop:margin-left-neg-6"> <div class="grid-col-12"> <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note"> As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.<br/> Learn more: <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a> | <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/"> PMC Copyright Notice </a> </div> </div> </div> <div class="grid-row pmc-wm desktop:margin-left-neg-6">  <main id="main-content" class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0" > <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-elsevierwt.png" alt="Elsevier Sponsored Documents logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Elsevier Sponsored Documents" title="Link to Elsevier Sponsored Documents" shape="default" href="https://doi.org/10.1016/S0140-6736(21)00677-2" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div> <div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Lancet</button></div>. 2021 May 1;397(10285):1646–1657. doi: <a href="https://doi.org/10.1016/S0140-6736(21)00677-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/S0140-6736(21)00677-2</a> </div> <nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu"> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Lancet%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li> <li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lancet%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Lancet%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li> <li role="presentation"><a href="?term=%22Lancet%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li> </ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs"> <hgroup><h1>Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study</h1></hgroup><div class="cg p"> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vasileiou%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Eleftheria Vasileiou</span></a><div hidden="hidden" id="id1"> <h3> <span class="name western">Eleftheria Vasileiou</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vasileiou%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eleftheria Vasileiou</span></a> </div> </div> <sup>a,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simpson%20CR%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Colin R Simpson</span></a><div hidden="hidden" id="id2"> <h3> <span class="name western">Colin R Simpson</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p"> <sup>c</sup>School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Simpson%20CR%22%5BAuthor%5D" class="usa-link"><span class="name western">Colin R Simpson</span></a> </div> </div> <sup>a,</sup><sup>c,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ting Shi</span></a><div hidden="hidden" id="id3"> <h3> <span class="name western">Ting Shi</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Ting Shi</span></a> </div> </div> <sup>a,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kerr%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Steven Kerr</span></a><div hidden="hidden" id="id4"> <h3> <span class="name western">Steven Kerr</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kerr%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Steven Kerr</span></a> </div> </div> <sup>a,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Agrawal%20U%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Utkarsh Agrawal</span></a><div hidden="hidden" id="id5"> <h3> <span class="name western">Utkarsh Agrawal</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>d</sup>School of Medicine, University of St Andrews, St Andrews, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Agrawal%20U%22%5BAuthor%5D" class="usa-link"><span class="name western">Utkarsh Agrawal</span></a> </div> </div> <sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Akbari%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ashley Akbari</span></a><div hidden="hidden" id="id6"> <h3> <span class="name western">Ashley Akbari</span>, <span class="degrees">MSc</span> </h3> <div class="p"> <sup>e</sup>Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Akbari%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ashley Akbari</span></a> </div> </div> <sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bedston%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Stuart Bedston</span></a><div hidden="hidden" id="id7"> <h3> <span class="name western">Stuart Bedston</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>e</sup>Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bedston%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stuart Bedston</span></a> </div> </div> <sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beggs%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jillian Beggs</span></a><div hidden="hidden" id="id8"> <h3> <span class="name western">Jillian Beggs</span>, <span class="degrees">BSc</span> </h3> <div class="p"> <sup>g</sup>The Health Data Research Hub for Respiratory Health, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beggs%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jillian Beggs</span></a> </div> </div> <sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bradley%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Declan Bradley</span></a><div hidden="hidden" id="id9"> <h3> <span class="name western">Declan Bradley</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>h</sup>Public Health Agency, Belfast, UK</div> <div class="p"> <sup>i</sup>Centre for Public Health, Queen's University Belfast, Belfast, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bradley%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Declan Bradley</span></a> </div> </div> <sup>h,</sup><sup>i</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chuter%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Antony Chuter</span></a><div hidden="hidden" id="id10"> <h3> <span class="name western">Antony Chuter</span>, <span class="degrees">FRCGP</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p"> <sup>g</sup>The Health Data Research Hub for Respiratory Health, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chuter%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Antony Chuter</span></a> </div> </div> <sup>a,</sup><sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Lusignan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Simon de Lusignan</span></a><div hidden="hidden" id="id11"> <h3> <span class="name western">Simon de Lusignan</span>, <span class="degrees">Prof, MD</span> </h3> <div class="p"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20Lusignan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon de Lusignan</span></a> </div> </div> <sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Docherty%20AB%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Annemarie B Docherty</span></a><div hidden="hidden" id="id12"> <h3> <span class="name western">Annemarie B Docherty</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Docherty%20AB%22%5BAuthor%5D" class="usa-link"><span class="name western">Annemarie B Docherty</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ford%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">David Ford</span></a><div hidden="hidden" id="id13"> <h3> <span class="name western">David Ford</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>f</sup>Health Informatics, Health Informatics Group, College of Medicine, Swansea University, Swansea, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ford%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">David Ford</span></a> </div> </div> <sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hobbs%20FDR%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">FD Richard Hobbs</span></a><div hidden="hidden" id="id14"> <h3> <span class="name western">FD Richard Hobbs</span>, <span class="degrees">Prof, F MedSci</span> </h3> <div class="p"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hobbs%20FDR%22%5BAuthor%5D" class="usa-link"><span class="name western">FD Richard Hobbs</span></a> </div> </div> <sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Joy%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Mark Joy</span></a><div hidden="hidden" id="id15"> <h3> <span class="name western">Mark Joy</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Joy%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mark Joy</span></a> </div> </div> <sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katikireddi%20SV%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Srinivasa Vittal Katikireddi</span></a><div hidden="hidden" id="id16"> <h3> <span class="name western">Srinivasa Vittal Katikireddi</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>k</sup>MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katikireddi%20SV%22%5BAuthor%5D" class="usa-link"><span class="name western">Srinivasa Vittal Katikireddi</span></a> </div> </div> <sup>k</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marple%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">James Marple</span></a><div hidden="hidden" id="id17"> <h3> <span class="name western">James Marple</span>, <span class="degrees">MD</span> </h3> <div class="p"> <sup>b</sup>Royal Infirmary of Edinburgh, NHS Lothian and Anaesthesia, Critical Care and Pain Medicine, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Marple%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">James Marple</span></a> </div> </div> <sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCowan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Colin McCowan</span></a><div hidden="hidden" id="id18"> <h3> <span class="name western">Colin McCowan</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>d</sup>School of Medicine, University of St Andrews, St Andrews, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCowan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Colin McCowan</span></a> </div> </div> <sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGagh%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Dylan McGagh</span></a><div hidden="hidden" id="id19"> <h3> <span class="name western">Dylan McGagh</span>, <span class="degrees">BSc</span> </h3> <div class="p"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGagh%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dylan McGagh</span></a> </div> </div> <sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McMenamin%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Jim McMenamin</span></a><div hidden="hidden" id="id20"> <h3> <span class="name western">Jim McMenamin</span>, <span class="degrees">MBChB</span> </h3> <div class="p"> <sup>l</sup>Public Health Scotland, Glasgow UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McMenamin%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jim McMenamin</span></a> </div> </div> <sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moore%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Emily Moore</span></a><div hidden="hidden" id="id21"> <h3> <span class="name western">Emily Moore</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>l</sup>Public Health Scotland, Glasgow UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moore%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emily Moore</span></a> </div> </div> <sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murray%20JLK%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Josephine LK Murray</span></a><div hidden="hidden" id="id22"> <h3> <span class="name western">Josephine LK Murray</span>, <span class="degrees">FFPH</span> </h3> <div class="p"> <sup>l</sup>Public Health Scotland, Glasgow UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Murray%20JLK%22%5BAuthor%5D" class="usa-link"><span class="name western">Josephine LK Murray</span></a> </div> </div> <sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Jiafeng Pan</span></a><div hidden="hidden" id="id23"> <h3> <span class="name western">Jiafeng Pan</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>n</sup>Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiafeng Pan</span></a> </div> </div> <sup>n</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ritchie%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Lewis Ritchie</span></a><div hidden="hidden" id="id24"> <h3> <span class="name western">Lewis Ritchie</span>, <span class="degrees">Prof Sir, MD</span> </h3> <div class="p"> <sup>o</sup>Academic Primary Care, University of Aberdeen School of Medicine and Dentistry, Aberdeen, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ritchie%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lewis Ritchie</span></a> </div> </div> <sup>o</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shah%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Syed Ahmar Shah</span></a><div hidden="hidden" id="id25"> <h3> <span class="name western">Syed Ahmar Shah</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shah%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Syed Ahmar Shah</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stock%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Sarah Stock</span></a><div hidden="hidden" id="id26"> <h3> <span class="name western">Sarah Stock</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stock%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sarah Stock</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Torabi%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Fatemeh Torabi</span></a><div hidden="hidden" id="id27"> <h3> <span class="name western">Fatemeh Torabi</span>, <span class="degrees">MSc</span> </h3> <div class="p"> <sup>e</sup>Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Torabi%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fatemeh Torabi</span></a> </div> </div> <sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsang%20RSM%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Ruby SM Tsang</span></a><div hidden="hidden" id="id28"> <h3> <span class="name western">Ruby SM Tsang</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tsang%20RSM%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruby SM Tsang</span></a> </div> </div> <sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wood%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Rachael Wood</span></a><div hidden="hidden" id="id29"> <h3> <span class="name western">Rachael Wood</span>, <span class="degrees">PhD</span> </h3> <div class="p"> <sup>m</sup>Clinical and Public Health Intelligence team, Public Health Scotland, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wood%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rachael Wood</span></a> </div> </div> <sup>m</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Woolhouse%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">Mark Woolhouse</span></a><div hidden="hidden" id="id30"> <h3> <span class="name western">Mark Woolhouse</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Woolhouse%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mark Woolhouse</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Robertson%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id31"><span class="name western">Chris Robertson</span></a><div hidden="hidden" id="id31"> <h3> <span class="name western">Chris Robertson</span>, <span class="degrees">Prof, PhD</span> </h3> <div class="p"> <sup>l</sup>Public Health Scotland, Glasgow UK</div> <div class="p"> <sup>n</sup>Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Robertson%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chris Robertson</span></a> </div> </div> <sup>l,</sup><sup>n,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sheikh%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id32"><span class="name western">Aziz Sheikh</span></a><div hidden="hidden" id="id32"> <h3> <span class="name western">Aziz Sheikh</span>, <span class="degrees">Prof, MD</span> </h3> <div class="p"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sheikh%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aziz Sheikh</span></a> </div> </div> <sup>a,</sup><sup>†,</sup><sup>*</sup> </div> <ul class="d-buttons inline-list"> <li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li> <li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li> </ul> <div class="d-panels font-secondary-light"> <div id="aip_a" class="d-panel p" style="display: none"> <div class="p" id="aff1"> <sup>a</sup>Usher Institute, The University of Edinburgh, Edinburgh, UK</div> <div id="aff2"> <sup>b</sup>Royal Infirmary of Edinburgh, NHS Lothian and Anaesthesia, Critical Care and Pain Medicine, The University of Edinburgh, Edinburgh, UK</div> <div id="aff3"> <sup>c</sup>School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand</div> <div id="aff4"> <sup>d</sup>School of Medicine, University of St Andrews, St Andrews, UK</div> <div id="aff5"> <sup>e</sup>Population Data Science, Swansea University Medical School, Swansea University, Swansea, UK</div> <div id="aff6"> <sup>f</sup>Health Informatics, Health Informatics Group, College of Medicine, Swansea University, Swansea, UK</div> <div id="aff7"> <sup>g</sup>The Health Data Research Hub for Respiratory Health, Edinburgh, UK</div> <div id="aff8"> <sup>h</sup>Public Health Agency, Belfast, UK</div> <div id="aff9"> <sup>i</sup>Centre for Public Health, Queen's University Belfast, Belfast, UK</div> <div id="aff10"> <sup>j</sup>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK</div> <div id="aff11"> <sup>k</sup>MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK</div> <div id="aff12"> <sup>l</sup>Public Health Scotland, Glasgow UK</div> <div id="aff13"> <sup>m</sup>Clinical and Public Health Intelligence team, Public Health Scotland, Edinburgh, UK</div> <div id="aff14"> <sup>n</sup>Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK</div> <div id="aff15"> <sup>o</sup>Academic Primary Care, University of Aberdeen School of Medicine and Dentistry, Aberdeen, UK</div> <div class="author-notes p"> <div class="fn" id="cor1"> <sup>*</sup><p class="display-inline">Correspondence to: Professor Aziz Sheikh, Usher Institute, The University of Edinburgh, Edinburgh EH8 9AG, UK <span>aziz.sheikh@ed.ac.uk</span></p> </div> <div class="fn" id="fn1"> <sup>*</sup><p class="display-inline" id="cenpara120">Contributed equally</p> </div> <div class="fn" id="fn2"> <sup>†</sup><p class="display-inline" id="cenpara130">Senior authors</p> </div> </div> </div> <div id="clp_a" class="d-panel p" style="display: none"> <div>© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license</div> <p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</p> <div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div> </div> </div> <div>PMCID: PMC8064669 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33901420/" class="usa-link">33901420</a> </div> <div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>See "<a href="/articles/PMC8064667/" class="usa-link">Hospital admissions due to COVID-19 in Scotland after one dose of vaccine</a>" on page 1601.</div></div> </div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ceab10"><h2>Summary</h2> <section id="sec1_pmc"><h3 class="pmc_sec_title">Background</h3> <p>The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effects of these vaccines is an urgent requirement. The aim of our study was to investigate the association between the mass roll-out of the first doses of these COVID-19 vaccines and hospital admissions for COVID-19.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3> <p>We did a prospective cohort study using the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19—EAVE II—database comprising linked vaccination, primary care, real-time reverse transcription-PCR testing, and hospital admission patient records for 5·4 million people in Scotland (about 99% of the population) registered at 940 general practices. Individuals who had previously tested positive were excluded from the analysis. A time-dependent Cox model and Poisson regression models with inverse propensity weights were fitted to estimate effectiveness against COVID-19 hospital admission (defined as 1–adjusted rate ratio) following the first dose of vaccine.</p></section><section id="sec3"><h3 class="pmc_sec_title">Findings</h3> <p>Between Dec 8, 2020, and Feb 22, 2021, a total of 1 331 993 people were vaccinated over the study period. The mean age of those vaccinated was 65·0 years (SD 16·2). The first dose of the BNT162b2 mRNA vaccine was associated with a vaccine effect of 91% (95% CI 85–94) for reduced COVID-19 hospital admission at 28–34 days post-vaccination. Vaccine effect at the same time interval for the ChAdOx1 vaccine was 88% (95% CI 75–94). Results of combined vaccine effects against hospital admission due to COVID-19 were similar when restricting the analysis to those aged 80 years and older (83%, 95% CI 72–89 at 28–34 days post-vaccination).</p></section><section id="sec4"><h3 class="pmc_sec_title">Interpretation</h3> <p>Mass roll-out of the first doses of the BNT162b2 mRNA and ChAdOx1 vaccines was associated with substantial reductions in the risk of hospital admission due to COVID-19 in Scotland. There remains the possibility that some of the observed effects might have been due to residual confounding.</p></section><section id="sec5"><h3 class="pmc_sec_title">Funding</h3> <p>UK Research and Innovation (Medical Research Council), Research and Innovation Industrial Strategy Challenge Fund, Health Data Research UK.</p></section></section><section id="cesec10"><h2 class="pmc_sec_title">Introduction</h2> <p id="para10">In December, 2019, there was an outbreak of the novel SARS-CoV-2 in Wuhan, China, which was later declared as the COVID-19 pandemic by <a href="https://covid19.who.int/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">WHO</a>. Since the beginning of the pandemic and as of April 20, 2021, more than 141 million cases and 3 millions deaths have been reported in more than 223 countries and territories worldwide. The UK has among the highest morbidity and mortality rates worldwide. Scotland has reported more than 24 000 hospital admissions and 7600 deaths due to COVID-19.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a></p> <p id="para20">Unprecedented investments have been made in vaccine technology, evaluation, and production in response to the pandemic. Authorisation of the first COVID-19 vaccines occurred soon after publication of the initial phase 3 safety and efficacy studies,<a href="#bib2" class="usa-link" aria-describedby="bib2"><sup>2</sup></a> and the UK was one of the first countries to license these vaccines for use.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a> As of April 13, 2021, first-dose vaccine coverage of about 50% has been reported in Scotland with more than 2·6 million vaccines administered across the Scottish population, and delivery targeted at specified priority groups of those most at risk of harm (including those aged 50 years and older and health-care workers; <a href="#sec1" class="usa-link">appendix p 1</a>).<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a><sup>, </sup><a href="#bib3" class="usa-link" aria-describedby="bib3"><sup>3</sup></a></p> <p id="para30">Clinical trials of all three vaccines authorised for use in the UK (ie, Pfizer–BioNTech, Oxford–AstraZeneca, and Moderna) have reported high vaccine efficacy. For the Pfizer–BioNTech vaccine (BNT162b2 mRNA COVID-19 vaccine), 95% efficacy was reported against laboratory-confirmed COVID-19.<a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> The Oxford–AstraZeneca vaccine was found to have 70% efficacy against COVID-19 illness among seronegative participants.<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a> The Moderna vaccine (mRNA-1273) was reported to have 94% efficacy against confirmed COVID-19 but, given that the first dose of mRNA-1273 was given in Scotland on April 7, 2021, it is therefore not included in this analysis.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a></p> <section class="bt xbox font-sm" id="cetextbox10"><h3 class="obj_head">Research in context.</h3> <p id="para50"><strong>Evidence before this study</strong></p> <p id="para60">We searched PubMed, medRxiv, and SSRN for observational studies, with no language restrictions, using the term “COVID-19 vaccine effect”. We searched for studies published between Dec 1, 2020, and March 2, 2021. We found one study from Israel, which included 596 618 individuals who received the BNT162b2 mRNA (Pfizer–BioNTech) vaccine and an equal number of controls. The study showed that 14–20 days after the first vaccination dose there was a vaccine effect of 74% (95% CI 56–86) for hospital admissions due to COVID-19. Public Health England has reported that the first dose vaccine effect against hospital admissions due to COVID-19 for the BNT162b2 mRNA and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccines is about 80%.</p> <p id="para70"><strong>Added value of this study</strong></p> <p id="para80">Current Scottish (UK) policy for use of vaccines against COVID-19 involves an offer of a first dose followed by a second dose 12 weeks later. To our knowledge, this is the first study of COVID-19 vaccine effect against hospital admissions for an entire nation after a single dose of vaccine. We found that a single dose of the BNT162b2 mRNA COVID-19 vaccine was associated with a vaccine effect of 91% (95% CI 85–94) for hospital admissions due to COVID-19 28–34 days after vaccination. A single dose of ChAdOx1 vaccine was associated with a vaccine effect of 88% (95% CI 75–94) at 28–34 days post-vaccination. Comparable vaccine effects were seen in those aged 80 years and older against hospital admissions due to COVID-19 with a high combined vaccine effect of 83% (95% CI 72–89) at 28–34 days after vaccination. For the same age group (≥80 years old) and at the same post-vaccination period (28–34 days), a vaccine effect of 88% (95% CI 76–94) was found for the BNT162b2 mRNA vaccine and 81% (60–91) for the ChAdOx1 vaccine.</p> <p id="para90"><strong>Implications of all the available evidence</strong></p> <p id="para100">We provide national evidence that the mass roll-out of first doses of the COVID-19 vaccines currently being used in the UK vaccination programme was associated with substantial reductions in risk of COVID-19 hospital admissions in the populations at highest risk for severe COVID-19 outcomes. However, we note that some of the observed effects might have been due to residual confounding.</p></section><p id="para110">Large post-licensure epidemiological studies are needed to complement the findings of pre-licensure trials to estimate the effectiveness of these vaccines at the population level in real-world settings.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a> The delayed second dose COVID-19 vaccination policy of the UK does not comply with the manufacturer guidance on timing between the first and second dose (ie, 21 days for Pfizer–BioNTech and 28 days for Oxford–AstraZeneca vaccines). Reflecting the need to gather evidence on this policy, we aimed to investigate the association between the first doses of the Pfizer–BioNTech and Oxford–AstraZeneca vaccines and hospital admissions in those with confirmed COVID-19 among high-risk adults in Scotland.</p></section><section id="cesec20"><h2 class="pmc_sec_title">Methods</h2> <section id="cesec30"><h3 class="pmc_sec_title">Study design and participants</h3> <p id="para120">We did an open, real-time prospective observational cohort study with national-level coverage in Scotland using a unique dataset consisting of linked vaccination, primary care, laboratory testing, hospital admission, and mortality data (<a href="#sec1" class="usa-link">appendix p 3</a>). Data were available for 5·4 million people in Scotland.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> Individuals who had previously tested positive with real-time reverse transcription-PCR (rtPCR) for SARS-CoV-2 infection before Dec 8, 2020, were excluded from this analysis. Ethical approval was obtained from the National Research Ethics Service Committee, Southeast Scotland 02 (reference number, 12/SS/0201), and Public Benefit and Privacy Panel for Health and Social Care (reference number, 1920–0279). We produced a <a href="https://bmjopen.bmj.com/content/10/6/e039097.info" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">protocol</a> before undertaking the analysis. We followed the Reporting of studies Conducted using Observational Routinely-collected Data<a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> checklist to guide transparent reporting of this cohort study (<a href="#sec1" class="usa-link">appendix pp 16–23</a>). Our <a href="https://github.com/EAVE-II/Covid-VE" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">analysis code</a> has been made publicly available.</p></section><section id="cesec40"><h3 class="pmc_sec_title">Procedures</h3> <p id="para130">By use of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19—EAVE II—database, primary care data derived from 940 general practices across Scotland were linked to the laboratory data from the Electronic Communication of Surveillance in Scotland (ECOSS),<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> the hospital admission data available from the Scottish Morbidity Record 01 database, and Rapid Preliminary Inpatient Data.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a> Vaccination data were available from general practices and the Turas Vaccination Management Tool (TVMT),<a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a> which is a web-based tool to capture vaccinations in the community and create real-time vaccination records. Laboratory data from ECOSS included all rtPCR test results from both National Health Service laboratories (Pillar 1) and Lighthouse Government laboratories (Pillar 2).<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a> Data were deterministically linked using the Community Health Index number, which is a unique identifier used for all health-care contact across Scotland.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a></p> <p id="para140">We studied the first doses of the BNT162b2 mRNA COVID-19 (also known as the Pfizer–BioNTech) vaccine<a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> and ChAdOx1 (AZD1222; also known as the Oxford–AstraZeneca) vaccine.<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a> An individual was defined as exposed if they received a single dose of vaccine between Dec 8, 2020, and Feb 22, 2021, with maximum follow-up time censored at Feb 22, 2021 (the latest event date). Vaccinated groups were stratified by time intervals including 0–6, 7–13, 14–20, 21–27, 28–34, 35–41, and 42 or more days post-vaccination, and by the type of vaccine received. Vaccination information was extracted from the general practitioner records and the TVMT system and included individuals vaccinated in general practices, community vaccination hubs, and other settings such as care homes.</p> <p id="para150">The primary outcome was vaccine effect, assessed as hospital admissions with COVID-19 as the main cause of admission, or hospital admission within 28 days of a positive rtPCR test for SARS-CoV-2 infection from Dec 8, 2020, to Feb 22, 2021. International Classification of Diseases-10 codes used for COVID-19 illness are presented in the <a href="#sec1" class="usa-link">appendix (p 5)</a>. A post-hoc sensitivity analysis was also carried out to assess any vaccine programme effects or residual confounding effects during the early post-vaccination period. An additional post-hoc exploratory ecological analysis was done to investigate the effect of lockdown measures on hospital admissions between September, 2020, and February, 2021.</p></section><section id="cesec50"><h3 class="pmc_sec_title">Statistical analysis</h3> <p id="para160">The primary analyses included vaccine effect estimates for vaccination status overall and for each vaccine type. The secondary analysis included vaccine effect estimates for vaccine status overall and for each vaccine type stratified by age groups (ages 18–64, 65–79, and ≥80 years). These were grouped to the completed year (ie, 64·5 years would be categorised as 18–64 years and 79·4 as 65–79 years).</p> <p id="para170">Baseline characteristics in the vaccinated and unvaccinated groups were described using proportions. We assessed the effect of one dose of either vaccine against hospital admissions due to laboratory-confirmed SARS-CoV-2 infection, or clinical diagnosis of COVID-19 on admission. Poisson regression adjusting for an offset representing the time at risk and time-dependent Cox models (considering the time at risk) were used to derive the rate ratios, hazard ratios, and 95% CIs for the association of vaccination with COVID-19 hospital admissions.</p> <p id="para180">Cox models included spline terms for age and number of rtPCR tests before vaccination (a marker for health-care workers, social-care workers, and care home residents who had repeated tests). Additional adjustments were made for sex, socioeconomic status, and underlying medical conditions at risk of COVID-19 illness with vaccination groups representing a time-dependent covariate. Calendar time intervals by week were included as stratification variables because the background epidemic was changing rapidly over the observation period. Poisson regression was used for the full adjustment and propensity weighting. This regression model used age groups in 5-year intervals as well as sex, deprivation, and number of previous tests. Additionally, the following comorbidity groups, all of which are associated with an increased risk of hospital admission, were included: type 1 and type 2 diabetes, high and low blood pressure, chronic obstructive pulmonary disease, chronic kidney disease, dementia, stroke, learning disorders, fractures, neurological conditions, chronic cardiac failure, asthma, epilepsy, blood cancer, liver cirrhosis, venous thromboembolism, peripheral vascular disease, atrial fibrillation, pulmonary hypertension, Parkinson's disease, rare pulmonary disorders, rheumatoid arthritis, and systemic lupus erythematosus.</p> <p id="para190">Both the Cox models and Poisson regression used sampling weights, which were used to correct for the size of the registered general practice population being greater than the population in Scotland (some due to recently deceased patients still being recorded in the patient records and individuals who had recently moved). These weights were derived by matching the age and sex numbers in the general practice data to the Scottish population data. This adjustment ensured that the denominators in the tables matched the Scottish population.</p> <p id="para200">The models were fit to a dataset with all events and a random sample, without replacement, of 100 individuals per event with sample weights calculated to represent the sampling fraction and thus ensure the correct calculation of the person-years at risk for the whole population. A combined weight was used in the statistical modelling. Finally, a propensity model for vaccination was developed using a logistic regression model including terms for age group by sex interaction, socioeconomic status, number of previous rtPCR tests, and number of clinical risk groups. The parameter estimates of this model were obtained from a 25% sample of the cohort and the propensity score calculated for the whole cohort. Inverse propensity score weights were used as a final adjustment in the regression models.<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a></p> <p id="para210">33 834 individuals received a second dose of the vaccine. Individuals who received two doses remained in the analysis for as long as they had one dose and were then censored at the date of the second dose. All statistical tests were two-tailed with a 5% significance level of p less than 0·05.</p> <p id="para220">At the baseline of our cohort (Dec 8, 2020), several population characteristics that could potentially confound the association between COVID-19 vaccination and the outcomes of interest were determined. These included age, sex, socioeconomic status measured by quintiles of the Scottish Index of Multiple Deprivation (1 refers to most deprived and 5 refers to least deprived),<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> residential settlement measured by the urban or rural 6-fold classification (1 refers to large urban areas and 6 refers to small remote rural areas),<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> and the number and types of comorbidities commonly associated with COVID-19 illness.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> To adjust for the residual confounding in which vaccines were not offered to or were declined by the most frail, we included a functional variable, namely dementia, in our covariate adjustment.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a></p> <p id="para230">We did several post-hoc sensitivity analyses to assess possible vaccine programme or residual confounding effects during the early period after vaccination (ie, <14 days when immunity should still be mounting).<a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> In particular, we carried out a falsification of exposure sensitivity analysis that involved re-running the analysis using a fictional date of vaccination 2 months before actual vaccination to determine the extent to which vaccine programme effects contributed to residual confounding. We have provided the overall predicted curves from the Cox proportional hazards model adjusting for covariates, with a stratification by calendar period (<a href="#sec1" class="usa-link">appendix pp 6–7</a>). An over-dispersed Poisson regression model was also carried out to assess the effect of the national lockdown on Dec 26, 2020, and the additional restrictions imposed on Jan 5, 2021, on hospital admissions due to COVID-19 in adults (age 18–64, 65–79, and 80 or older).</p> <p id="para240">The analyses were carried out by one statistician (CR) and independently checked by a second statistician (EM). All statistical analyses were done with statistical <a href="https://www.r-project.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">software R</a> (version 3.6.1).</p> <p id="para250">There was missing data for deprivation, urban-rural status (patient postcode was not available), smoking status, and blood pressure (value had not been recorded). Missing data were handled by creating a separate group for these individuals.</p></section><section id="cesec60"><h3 class="pmc_sec_title">Role of the funding source</h3> <p id="para260">The funder of the study had no role in study design, data collection, data analysis, data interpretation, or the writing of the report.</p></section></section><section id="cesec70"><h2 class="pmc_sec_title">Results</h2> <p id="para270">Between Dec 8, 2020, and Feb 15, 2021, 1 331 993 (30%) of 4 409 588 adults aged 18 years or older were vaccinated in our study. Rapid uptake of the BNT162b2 mRNA and ChAdOx1 vaccines was observed over the study period (<a href="#fig1" class="usa-link">figure 1</a>; <a href="#tbl1" class="usa-link">table 1</a>), with 65–79 years the age group with the highest uptake (85·9%; 651 942 of 758 946). For the BNT162b2 mRNA vaccine, the highest uptake was found in patients younger than 65 years, whereas for the ChAdOx1 vaccine, highest vaccine uptake was found in patients aged 65–79 years (<a href="#tbl1" class="usa-link">table 1</a>). Vaccine uptake for both vaccines combined was higher in women (35·1%, 799 765 of 2 280 907 <em>vs</em> 25·0%, 532 228 of 2 128 681 men). A low socioeconomic status was associated with lower vaccination rates than was a high socioeconomic status (level 1, 26·1% <em>vs</em> levels 3–5, 31·2–32·0%). Those living in large urban areas had an uptake of 25%, which was lower than all other residential categories. Vaccine coverage increased with the number of comorbidities, from 21·2% with none to 80·0% with five or more. Ex-smokers had a coverage of 48·7%, which was higher than the similar uptake recorded for both smokers and non-smokers. Vaccine coverage also increased with increasing blood pressure. These differences in the clinical factors were probably associated with age. Baseline characteristics of participants older than 80 years by vaccine status and timing are presented in the <a href="#sec1" class="usa-link">appendix (pp 10–12</a>).</p> <figure class="fig xbox font-sm" id="fig1"><h3 class="obj_head">Figure 1.</h3> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=8102466_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca8b/8102466/5c82ac07fb2f/gr1.jpg" loading="lazy" height="1101" width="686" alt="Figure 1"></a></p> <div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>COVID-19 vaccine uptake</p> <p>(A) Uptake over time by age group. (B) Uptake by age and vaccine type.</p></figcaption></figure><section class="tw xbox font-sm" id="tbl1"><h3 class="obj_head">Table 1.</h3> <div class="caption p"><p>Baseline characteristics by vaccine status</p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"> <thead> <tr> <th colspan="1" rowspan="1"></th> <th colspan="3" align="left" rowspan="1"> <strong>Vaccinated</strong><hr> </th> <th align="left" colspan="1" rowspan="1"><strong>Unvaccinated (n=3 077 595)</strong></th> <th align="left" colspan="1" rowspan="1"><strong>Uptake (% of total for both vaccines)</strong></th> </tr> <tr> <th colspan="1" rowspan="1"></th> <th align="left" colspan="1" rowspan="1">Both vaccines (n=1 331 993)</th> <th align="left" colspan="1" rowspan="1">BNT162b2 (Pfizer–BioNTech) (n=711 839)</th> <th align="left" colspan="1" rowspan="1">ChAdOx1 (Oxford–AstraZeneca) (n=620 154)</th> <th colspan="1" rowspan="1"></th> <th colspan="1" rowspan="1"></th> </tr> </thead> <tbody> <tr><td colspan="6" align="left" rowspan="1"><strong>Sex</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Female</td> <td align="left" colspan="1" rowspan="1">799 765 (60·0%)</td> <td align="left" colspan="1" rowspan="1">456 667 (64·2%)</td> <td align="left" colspan="1" rowspan="1">343 098 (55·3%)</td> <td align="left" colspan="1" rowspan="1">1 481 142 (48·1%)</td> <td align="left" colspan="1" rowspan="1">799 765/2 280 907 (35·1%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Male</td> <td align="left" colspan="1" rowspan="1">532 228 (40·0%)</td> <td align="left" colspan="1" rowspan="1">255 172 (35·8%)</td> <td align="left" colspan="1" rowspan="1">277 056 (44·7%)</td> <td align="left" colspan="1" rowspan="1">1 596 453 (51·9%)</td> <td align="left" colspan="1" rowspan="1">532 228/2 128 681 (25·0%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"><strong>Age group, years</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">18–64</td> <td align="left" colspan="1" rowspan="1">470 960 (35·4%)</td> <td align="left" colspan="1" rowspan="1">359 434 (50·5%)</td> <td align="left" colspan="1" rowspan="1">111 526 (18·0%)</td> <td align="left" colspan="1" rowspan="1">2 913 484 (94·7%)</td> <td align="left" colspan="1" rowspan="1">470 960/3 384 444 (13·9%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">65–79</td> <td align="left" colspan="1" rowspan="1">651 924 (48·9%)</td> <td align="left" colspan="1" rowspan="1">315 620 (44·3%)</td> <td align="left" colspan="1" rowspan="1">336 304 (54·2%)</td> <td align="left" colspan="1" rowspan="1">107 022 (3·5%)</td> <td align="left" colspan="1" rowspan="1">651 924/758 946 (85·9%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">≥80</td> <td align="left" colspan="1" rowspan="1">209 109 (15·7%)</td> <td align="left" colspan="1" rowspan="1">36 785 (5·2%)</td> <td align="left" colspan="1" rowspan="1">172 324 (27·8%)</td> <td align="left" colspan="1" rowspan="1">57 089 (1·9%)</td> <td align="left" colspan="1" rowspan="1">209 109/266 198 (78·6%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"> <strong>Socioeconomic status</strong><a href="#tbl1fn1" class="usa-link"><sup>*</sup></a> </td></tr> <tr> <td align="left" colspan="1" rowspan="1">1</td> <td align="left" colspan="1" rowspan="1">225 951 (17·0%)</td> <td align="left" colspan="1" rowspan="1">126 858 (17·8%)</td> <td align="left" colspan="1" rowspan="1">99 093 (16·0%)</td> <td align="left" colspan="1" rowspan="1">640 087 (20·8%)</td> <td align="left" colspan="1" rowspan="1">225 951/866 038 (26·1%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">2</td> <td align="left" colspan="1" rowspan="1">259 785 (19·5%)</td> <td align="left" colspan="1" rowspan="1">140 337 (19·7%)</td> <td align="left" colspan="1" rowspan="1">119 448 (19·3%)</td> <td align="left" colspan="1" rowspan="1">606 554 (19·7%)</td> <td align="left" colspan="1" rowspan="1">259 785/866 339 (30·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">3</td> <td align="left" colspan="1" rowspan="1">279 616 (21·0%)</td> <td align="left" colspan="1" rowspan="1">142 783 (20·1%)</td> <td align="left" colspan="1" rowspan="1">136 833 (22·1%)</td> <td align="left" colspan="1" rowspan="1">593 487 (19·3%)</td> <td align="left" colspan="1" rowspan="1">279 616/873 103 (32·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">4</td> <td align="left" colspan="1" rowspan="1">283 288 (21·3%)</td> <td align="left" colspan="1" rowspan="1">151 265 (21·2%)</td> <td align="left" colspan="1" rowspan="1">132 023 (21·3%)</td> <td align="left" colspan="1" rowspan="1">592 476 (19·3%)</td> <td align="left" colspan="1" rowspan="1">283 288/875 764 (32·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">276 680 (20·8%)</td> <td align="left" colspan="1" rowspan="1">146 461 (20·6%)</td> <td align="left" colspan="1" rowspan="1">130 219 (21·0%)</td> <td align="left" colspan="1" rowspan="1">609 927 (19·8%)</td> <td align="left" colspan="1" rowspan="1">276 680/886 607 (31·2%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Unknown</td> <td align="left" colspan="1" rowspan="1">6673 (0·5%)</td> <td align="left" colspan="1" rowspan="1">4135 (0·6%)</td> <td align="left" colspan="1" rowspan="1">2538 (0·4%)</td> <td align="left" colspan="1" rowspan="1">35 064 (1·1%)</td> <td align="left" colspan="1" rowspan="1">6673/41 737 (16·0%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"> <strong>Residential settlement</strong><a href="#tbl1fn2" class="usa-link"><sup>†</sup></a> </td></tr> <tr> <td align="left" colspan="1" rowspan="1">1</td> <td align="left" colspan="1" rowspan="1">398 251 (29·9%)</td> <td align="left" colspan="1" rowspan="1">217 396 (30·5%)</td> <td align="left" colspan="1" rowspan="1">180 855 (29·2%)</td> <td align="left" colspan="1" rowspan="1">1 192 363 (38·7%)</td> <td align="left" colspan="1" rowspan="1">398 251/1 590 644 (25·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">2</td> <td align="left" colspan="1" rowspan="1">499 274 (37·5%)</td> <td align="left" colspan="1" rowspan="1">279 933 (39·3%)</td> <td align="left" colspan="1" rowspan="1">219 341 (35·4%)</td> <td align="left" colspan="1" rowspan="1">1 052 938 (34·2%)</td> <td align="left" colspan="1" rowspan="1">499 274/1 552 212 (32·2%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">3</td> <td align="left" colspan="1" rowspan="1">133 842 (10·0%)</td> <td align="left" colspan="1" rowspan="1">68 411 (9·6%)</td> <td align="left" colspan="1" rowspan="1">65 431 (10·6%)</td> <td align="left" colspan="1" rowspan="1">269 309 (8·8%)</td> <td align="left" colspan="1" rowspan="1">133 842/403 151 (33·2%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">4</td> <td align="left" colspan="1" rowspan="1">79 993 (6·0%)</td> <td align="left" colspan="1" rowspan="1">36 623 (5·1%)</td> <td align="left" colspan="1" rowspan="1">43 370 (7·0%)</td> <td align="left" colspan="1" rowspan="1">131 373 (4·3%)</td> <td align="left" colspan="1" rowspan="1">79 993/211 366 (37·8%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">129 389 (9·7%)</td> <td align="left" colspan="1" rowspan="1">62 956 (8·8%)</td> <td align="left" colspan="1" rowspan="1">66 433 (10·7%)</td> <td align="left" colspan="1" rowspan="1">263 175 (8·6%)</td> <td align="left" colspan="1" rowspan="1">129 389/392 564 (33·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">6</td> <td align="left" colspan="1" rowspan="1">84 571 (6·3%)</td> <td align="left" colspan="1" rowspan="1">42 385 (6·0%)</td> <td align="left" colspan="1" rowspan="1">42 186 (6·8%)</td> <td align="left" colspan="1" rowspan="1">133 373 (4·3%)</td> <td align="left" colspan="1" rowspan="1">84 571/217 944 (38·8%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Unknown</td> <td align="left" colspan="1" rowspan="1">6673 (0·5%)</td> <td align="left" colspan="1" rowspan="1">4135 (0·6%)</td> <td align="left" colspan="1" rowspan="1">2538 (0·4%)</td> <td align="left" colspan="1" rowspan="1">35 064 (1·1%)</td> <td align="left" colspan="1" rowspan="1">6673/41 737 (16·0%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"><strong>Number of comorbidities</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">561 329 (42·1%)</td> <td align="left" colspan="1" rowspan="1">358 088 (50·3%)</td> <td align="left" colspan="1" rowspan="1">203 241 (32·8%)</td> <td align="left" colspan="1" rowspan="1">2 086 239 (67·8%)</td> <td align="left" colspan="1" rowspan="1">561 329/2 647 568 (21·2%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">1</td> <td align="left" colspan="1" rowspan="1">379 133 (28·5%)</td> <td align="left" colspan="1" rowspan="1">201 507 (28·3%)</td> <td align="left" colspan="1" rowspan="1">177 626 (28·6%)</td> <td align="left" colspan="1" rowspan="1">723 055 (23·5%)</td> <td align="left" colspan="1" rowspan="1">379 133/1 102 188 (34·4%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">2</td> <td align="left" colspan="1" rowspan="1">204 988 (15·4%)</td> <td align="left" colspan="1" rowspan="1">86 722 (12·2%)</td> <td align="left" colspan="1" rowspan="1">118 266 (19·1%)</td> <td align="left" colspan="1" rowspan="1">192 945 (6·3%)</td> <td align="left" colspan="1" rowspan="1">204 988/397 933 (51·5%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">3</td> <td align="left" colspan="1" rowspan="1">102 835 (7·7%)</td> <td align="left" colspan="1" rowspan="1">37 374 (5·3%)</td> <td align="left" colspan="1" rowspan="1">65 461 (10·6%)</td> <td align="left" colspan="1" rowspan="1">51 005 (1·7%)</td> <td align="left" colspan="1" rowspan="1">102 835/153 840 (66·8%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">4</td> <td align="left" colspan="1" rowspan="1">49 289 (3·7%)</td> <td align="left" colspan="1" rowspan="1">16 700 (2·3%)</td> <td align="left" colspan="1" rowspan="1">32 589 (5·3%)</td> <td align="left" colspan="1" rowspan="1">15 763 (0·5%)</td> <td align="left" colspan="1" rowspan="1">49 289/65 052 (75·8%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">≥5</td> <td align="left" colspan="1" rowspan="1">34 419 (2·6%)</td> <td align="left" colspan="1" rowspan="1">11 448 (1·6%)</td> <td align="left" colspan="1" rowspan="1">22 971 (3·7%)</td> <td align="left" colspan="1" rowspan="1">8589 (0·3%)</td> <td align="left" colspan="1" rowspan="1">34 419/43 008 (80·0%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"><strong>Type of comorbidity</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Asthma</td> <td align="left" colspan="1" rowspan="1">175 171 (13·2%)</td> <td align="left" colspan="1" rowspan="1">91 175 (12·8%)</td> <td align="left" colspan="1" rowspan="1">83 996 (13·5%)</td> <td align="left" colspan="1" rowspan="1">384 091 (12·5%)</td> <td align="left" colspan="1" rowspan="1">175 171/559 262 (31·3%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Chronic kidney condition<a href="#tbl1fn3" class="usa-link"><sup>‡</sup></a> (stage 3)</td> <td align="left" colspan="1" rowspan="1">133 393 (10·0%)</td> <td align="left" colspan="1" rowspan="1">41 172 (5·8%)</td> <td align="left" colspan="1" rowspan="1">92 221 (14·9%)</td> <td align="left" colspan="1" rowspan="1">28 140 (0·9%)</td> <td align="left" colspan="1" rowspan="1">133 393/161 533 (82·6%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Liver cirrhosis</td> <td align="left" colspan="1" rowspan="1">11 821 (0·9%)</td> <td align="left" colspan="1" rowspan="1">5075 (0·7%)</td> <td align="left" colspan="1" rowspan="1">6746 (1·1%)</td> <td align="left" colspan="1" rowspan="1">11 518 (0·4%)</td> <td align="left" colspan="1" rowspan="1">11 821/23 339 (50·6%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Chronic neurological condition</td> <td align="left" colspan="1" rowspan="1">8395 (0·6%)</td> <td align="left" colspan="1" rowspan="1">3413 (0·5%)</td> <td align="left" colspan="1" rowspan="1">4982 (0·8%)</td> <td align="left" colspan="1" rowspan="1">9718 (0·3%)</td> <td align="left" colspan="1" rowspan="1">8395/18 113 (46·3%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Heart failure</td> <td align="left" colspan="1" rowspan="1">35 998 (2·7%)</td> <td align="left" colspan="1" rowspan="1">11 016 (1·5%)</td> <td align="left" colspan="1" rowspan="1">24 982 (4·0%)</td> <td align="left" colspan="1" rowspan="1">12 103 (0·4%)</td> <td align="left" colspan="1" rowspan="1">35 998/48 101 (74·8%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Diabetes (type 1)</td> <td align="left" colspan="1" rowspan="1">6840 (0·5%)</td> <td align="left" colspan="1" rowspan="1">3651 (0·5%)</td> <td align="left" colspan="1" rowspan="1">3189 (0·5%)</td> <td align="left" colspan="1" rowspan="1">14 582 (0·5%)</td> <td align="left" colspan="1" rowspan="1">6840/21 422 (31·9%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Diabetes (type 2)</td> <td align="left" colspan="1" rowspan="1">156 720 (11·8%)</td> <td align="left" colspan="1" rowspan="1">64 426 (9·1%)</td> <td align="left" colspan="1" rowspan="1">92 294 (14·9%)</td> <td align="left" colspan="1" rowspan="1">101 821 (3·3%)</td> <td align="left" colspan="1" rowspan="1">156 720/258 541 (60·6%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Dementia</td> <td align="left" colspan="1" rowspan="1">32 317 (2·4%)</td> <td align="left" colspan="1" rowspan="1">16 993 (2·4%)</td> <td align="left" colspan="1" rowspan="1">15 324 (2·5%)</td> <td align="left" colspan="1" rowspan="1">5493 (0·2%)</td> <td align="left" colspan="1" rowspan="1">32 317/37 810 (85·5%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Coronary heart disease</td> <td align="left" colspan="1" rowspan="1">146 465 (11·0%)</td> <td align="left" colspan="1" rowspan="1">52 895 (7·4%)</td> <td align="left" colspan="1" rowspan="1">93 570 (15·1%)</td> <td align="left" colspan="1" rowspan="1">55 643 (1·8%)</td> <td align="left" colspan="1" rowspan="1">146 465/202 108 (72·5%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"><strong>Smoking status</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Ex-smoker</td> <td align="left" colspan="1" rowspan="1">277 240 (20·8%)</td> <td align="left" colspan="1" rowspan="1">123 234 (17·3%)</td> <td align="left" colspan="1" rowspan="1">154 006 (24·8%)</td> <td align="left" colspan="1" rowspan="1">291 792 (9·5%)</td> <td align="left" colspan="1" rowspan="1">277 240/569 032 (48·7%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Smoker</td> <td align="left" colspan="1" rowspan="1">312 302 (23·4%)</td> <td align="left" colspan="1" rowspan="1">162 076 (22·8%)</td> <td align="left" colspan="1" rowspan="1">150 226 (24·2%)</td> <td align="left" colspan="1" rowspan="1">595 547 (19·4%)</td> <td align="left" colspan="1" rowspan="1">312 302/907 849 (34·4%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Non-smoker</td> <td align="left" colspan="1" rowspan="1">510 325 (38·3%)</td> <td align="left" colspan="1" rowspan="1">281 309 (39·5%)</td> <td align="left" colspan="1" rowspan="1">229 016 (36·9%)</td> <td align="left" colspan="1" rowspan="1">1 167 424 (37·9%)</td> <td align="left" colspan="1" rowspan="1">510 325/1 677 749 (30·4%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Unknown</td> <td align="left" colspan="1" rowspan="1">232 126 (17·4%)</td> <td align="left" colspan="1" rowspan="1">145 220 (20·4%)</td> <td align="left" colspan="1" rowspan="1">86 906 (14·0%)</td> <td align="left" colspan="1" rowspan="1">1 022 833 (33·2%)</td> <td align="left" colspan="1" rowspan="1">232 126/1 254 959 (18·5%)</td> </tr> <tr><td colspan="6" align="left" rowspan="1"><strong>Blood pressure (systolic/diastolic)</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Very high (>160/100 mm Hg)</td> <td align="left" colspan="1" rowspan="1">39 468 (3·0%)</td> <td align="left" colspan="1" rowspan="1">16 872 (2·4%)</td> <td align="left" colspan="1" rowspan="1">22 596 (3·6%)</td> <td align="left" colspan="1" rowspan="1">44 656 (1·5%)</td> <td align="left" colspan="1" rowspan="1">39 468/84 124 (46·9%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">High (141–160/91–100 mm Hg)</td> <td align="left" colspan="1" rowspan="1">182 220 (13·7%)</td> <td align="left" colspan="1" rowspan="1">80 785 (11·3%)</td> <td align="left" colspan="1" rowspan="1">101 435 (16·4%)</td> <td align="left" colspan="1" rowspan="1">216 560 (7·0%)</td> <td align="left" colspan="1" rowspan="1">182 220/398 780 (45·7%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Normal (110–140/65–90 mm Hg)</td> <td align="left" colspan="1" rowspan="1">855 123 (64·2%)</td> <td align="left" colspan="1" rowspan="1">452 231 (63·5%)</td> <td align="left" colspan="1" rowspan="1">402 892 (65·0%)</td> <td align="left" colspan="1" rowspan="1">1 497 236 (48·6%)</td> <td align="left" colspan="1" rowspan="1">855 123/2 352 359 (36·4%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Low (<110/65 mm Hg)</td> <td align="left" colspan="1" rowspan="1">13 006 (1·0%)</td> <td align="left" colspan="1" rowspan="1">7130 (1·0%)</td> <td align="left" colspan="1" rowspan="1">5876 (0·9%)</td> <td align="left" colspan="1" rowspan="1">40 673 (1·3%)</td> <td align="left" colspan="1" rowspan="1">13 006/53 679 (24·2%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Unknown</td> <td align="left" colspan="1" rowspan="1">158 199 (11·9%)</td> <td align="left" colspan="1" rowspan="1">98 989 (13·9%)</td> <td align="left" colspan="1" rowspan="1">59 210 (9·5%)</td> <td align="left" colspan="1" rowspan="1">673 071 (21·9%)</td> <td align="left" colspan="1" rowspan="1">158 199/831 270 (19·0%)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">No investigation</td> <td align="left" colspan="1" rowspan="1">83 977 (6·3%)</td> <td align="left" colspan="1" rowspan="1">55 832 (7·8%)</td> <td align="left" colspan="1" rowspan="1">28 145 (4·5%)</td> <td align="left" colspan="1" rowspan="1">605 400 (19·7%)</td> <td align="left" colspan="1" rowspan="1">83 977/689 377 (12·2%)</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <div class="tw-foot p"> <div class="fn" id="fn3"><p>Data are n (%) or n/N (%).</p></div> <div class="fn" id="tbl1fn1"> <sup>*</sup><p class="display-inline" id="cenpara10">1 indicates most deprived, 5 indicates least deprived.</p> </div> <div class="fn" id="tbl1fn2"> <sup>†</sup><p class="display-inline" id="cenpara20">1 indicates a large urban area, 6 indicates a remote rural area.</p> </div> <div class="fn" id="tbl1fn3"> <sup>‡</sup><p class="display-inline" id="cenpara30">Stage 3 chronic kidney disease refers to an estimated glomerular filtration rate of 30–59 mL per min.</p> </div> </div></section><p id="para280">There was an overall downturn in the number of COVID-19 admissions to hospital over the study period (<a href="#fig2" class="usa-link">figure 2</a>). This overall effect was not due to the vaccination programme because a downward trend was observed before mass vaccination. However, by use of an over-dispersed Poisson regression model, we note that hospital admissions declined more markedly in those aged 80 years and older, who were the first to be vaccinated and of whom 50% had been vaccinated by the end of the third week in January, 2021, compared with those aged 18–64 years, and that rate of decline accelerated in those aged 80 years and older (<a href="#fig3" class="usa-link">figure 3</a>; <a href="#sec1" class="usa-link">appendix pp 13–14</a>).</p> <figure class="fig xbox font-sm" id="fig2"><h3 class="obj_head">Figure 2.</h3> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=8102466_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca8b/8102466/40f954330d6c/gr2.jpg" loading="lazy" height="513" width="686" alt="Figure 2"></a></p> <div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>COVID-19 hospital admissions over time by age group</p></figcaption></figure><figure class="fig xbox font-sm" id="fig3"><h3 class="obj_head">Figure 3.</h3> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=8102466_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca8b/8102466/75a1fb3e77bb/gr3.jpg" loading="lazy" height="516" width="685" alt="Figure 3"></a></p> <div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>COVID-19 hospital admissions by age group from September, 2020, to February, 2021</p> <p>The black dotted vertical line represents the start of vaccination (Dec 8, 2020) and the blue dotted lines represent the two lockdowns on Dec 26, 2020, and Jan 5, 2021. The smooth lines are obtained from fitting a generalised additive Poisson model to the admissions.</p></figcaption></figure><p id="para290">We found that vaccine effect at 28–34 days post-vaccination against COVID-19 hospital admissions among those receiving the first dose of the vaccine BNT162b2 was 91% (95% CI 85–94) and for ChAdOx1 was 88% (75–94; <a href="#tbl2" class="usa-link">table 2</a>).</p> <section class="tw xbox font-sm" id="tbl2"><h3 class="obj_head">Table 2.</h3> <div class="caption p"><p>COVID-19 hospital admissions and days post-vaccination by vaccination status and type</p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"> <thead><tr> <th colspan="1" rowspan="1"></th> <th align="left" colspan="1" rowspan="1"><strong>Person-years</strong></th> <th align="left" colspan="1" rowspan="1"><strong>Number of events</strong></th> <th align="left" colspan="1" rowspan="1"> <strong>Age-adjusted RRs (95% CI)</strong><a href="#tbl2fn1" class="usa-link"><sup>*</sup></a> </th> <th align="left" colspan="1" rowspan="1"> <strong>Full-adjusted RRs (95% CI)</strong><a href="#tbl2fn2" class="usa-link"><sup>†</sup></a> </th> <th align="left" colspan="1" rowspan="1"> <strong>Full and inverse propensity weighting adjusted RRs (95% CI)</strong><a href="#tbl2fn3" class="usa-link"><sup>‡</sup></a> </th> <th align="left" colspan="1" rowspan="1"><strong>Vaccine programme effect (95% CI)</strong></th> </tr></thead> <tbody> <tr><td colspan="7" align="left" rowspan="1"><strong>Vaccinated overall</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">831 226</td> <td align="left" colspan="1" rowspan="1">7698</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">19 917</td> <td align="left" colspan="1" rowspan="1">156</td> <td align="left" colspan="1" rowspan="1">0·43 (0·37 to 0·50)</td> <td align="left" colspan="1" rowspan="1">0·38 (0·32 to 0·44)</td> <td align="left" colspan="1" rowspan="1">0·25 (0·21 to 0·29)</td> <td align="left" colspan="1" rowspan="1">75% (71 to 79)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">19 690</td> <td align="left" colspan="1" rowspan="1">258</td> <td align="left" colspan="1" rowspan="1">0·67 (0·59 to 0·76)</td> <td align="left" colspan="1" rowspan="1">0·63 (0·56 to 0·72)</td> <td align="left" colspan="1" rowspan="1">0·46 (0·41 to 0·52)</td> <td align="left" colspan="1" rowspan="1">54% (48 to 59)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">13 426</td> <td align="left" colspan="1" rowspan="1">154</td> <td align="left" colspan="1" rowspan="1">0·54 (0·46 to 0·63)</td> <td align="left" colspan="1" rowspan="1">0·51 (0·43 to 0·60)</td> <td align="left" colspan="1" rowspan="1">0·33 (0·28 to 0·39)</td> <td align="left" colspan="1" rowspan="1">67% (61 to 72)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">9119</td> <td align="left" colspan="1" rowspan="1">72</td> <td align="left" colspan="1" rowspan="1">0·37 (0·29 to 0·46)</td> <td align="left" colspan="1" rowspan="1">0·33 (0·26 to 0·42)</td> <td align="left" colspan="1" rowspan="1">0·24 (0·19 to 0·30)</td> <td align="left" colspan="1" rowspan="1">76% (70 to 81)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">6252</td> <td align="left" colspan="1" rowspan="1">30</td> <td align="left" colspan="1" rowspan="1">0·25 (0·17 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·15 to 0·30)</td> <td align="left" colspan="1" rowspan="1">0·11 (0·08 to 0·17)</td> <td align="left" colspan="1" rowspan="1">89% (83 to 92)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">3822</td> <td align="left" colspan="1" rowspan="1">21</td> <td align="left" colspan="1" rowspan="1">0·36 (0·23 to 0·55)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·15 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·22 (0·15 to 0·32)</td> <td align="left" colspan="1" rowspan="1">78% (68 to 85)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">6047</td> <td align="left" colspan="1" rowspan="1">32</td> <td align="left" colspan="1" rowspan="1">0·51 (0·36 to 0·72)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·19 to 0·40)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·19 to 0·35)</td> <td align="left" colspan="1" rowspan="1">74% (65 to 81)</td> </tr> <tr><td colspan="7" align="left" rowspan="1"><strong>BNT162b2 (Pfizer–BioNTech)</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">734 031</td> <td align="left" colspan="1" rowspan="1">6671</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">10 517</td> <td align="left" colspan="1" rowspan="1">34</td> <td align="left" colspan="1" rowspan="1">0·18 (0·13 to 0·25)</td> <td align="left" colspan="1" rowspan="1">0·15 (0·10 to 0·21)</td> <td align="left" colspan="1" rowspan="1">0·14 (0·10 to 0·19)</td> <td align="left" colspan="1" rowspan="1">86% (81 to 90)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">10 991</td> <td align="left" colspan="1" rowspan="1">119</td> <td align="left" colspan="1" rowspan="1">0·57 (0·48 to 0·69)</td> <td align="left" colspan="1" rowspan="1">0·42 (0·35 to 0·51)</td> <td align="left" colspan="1" rowspan="1">0·47 (0·41 to 0·55)</td> <td align="left" colspan="1" rowspan="1">53% (45 to 59)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">7684</td> <td align="left" colspan="1" rowspan="1">71</td> <td align="left" colspan="1" rowspan="1">0·51 (0·40 to 0·64)</td> <td align="left" colspan="1" rowspan="1">0·31 (0·24 to 0·39)</td> <td align="left" colspan="1" rowspan="1">0·31 (0·25 to 0·38)</td> <td align="left" colspan="1" rowspan="1">69% (62 to 75)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">5672</td> <td align="left" colspan="1" rowspan="1">38</td> <td align="left" colspan="1" rowspan="1">0·41 (0·30 to 0·57)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·15 to 0·29)</td> <td align="left" colspan="1" rowspan="1">0·22 (0·17 to 0·29)</td> <td align="left" colspan="1" rowspan="1">78% (71 to 83)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">4585</td> <td align="left" colspan="1" rowspan="1">19</td> <td align="left" colspan="1" rowspan="1">0·26 (0·16 to 0·40)</td> <td align="left" colspan="1" rowspan="1">0·13 (0·08 to 0·21)</td> <td align="left" colspan="1" rowspan="1">0·09 (0·06 to 0·15)</td> <td align="left" colspan="1" rowspan="1">91% (85 to 94)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">3292</td> <td align="left" colspan="1" rowspan="1">20</td> <td align="left" colspan="1" rowspan="1">0·40 (0·26 to 0·62)</td> <td align="left" colspan="1" rowspan="1">0·18 (0·11 to 0·28)</td> <td align="left" colspan="1" rowspan="1">0·22 (0·15 to 0·31)</td> <td align="left" colspan="1" rowspan="1">78% (69 to 85)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">5996</td> <td align="left" colspan="1" rowspan="1">31</td> <td align="left" colspan="1" rowspan="1">0·38 (0·26 to 0·54)</td> <td align="left" colspan="1" rowspan="1">0·20 (0·14 to 0·28)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·17 to 0·32)</td> <td align="left" colspan="1" rowspan="1">77% (68 to 83)</td> </tr> <tr><td colspan="7" align="left" rowspan="1"><strong>ChAdOx1 (Oxford–AstraZeneca)</strong></td></tr> <tr> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">743 142</td> <td align="left" colspan="1" rowspan="1">7252</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">9222</td> <td align="left" colspan="1" rowspan="1">122</td> <td align="left" colspan="1" rowspan="1">0·46 (0·38 to 0·55)</td> <td align="left" colspan="1" rowspan="1">0·43 (0·35 to 0·51)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·23 to 0·34)</td> <td align="left" colspan="1" rowspan="1">72% (66 to 77)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl2fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">8699</td> <td align="left" colspan="1" rowspan="1">139</td> <td align="left" colspan="1" rowspan="1">0·48 (0·41 to 0·57)</td> <td align="left" colspan="1" rowspan="1">0·53 (0·44 to 0·63)</td> <td align="left" colspan="1" rowspan="1">0·32 (0·27 to 0·39)</td> <td align="left" colspan="1" rowspan="1">68% (61 to 73)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">5742</td> <td align="left" colspan="1" rowspan="1">83</td> <td align="left" colspan="1" rowspan="1">0·38 (0·30 to 0·47)</td> <td align="left" colspan="1" rowspan="1">0·47 (0·37 to 0·58)</td> <td align="left" colspan="1" rowspan="1">0·27 (0·21 to 0·34)</td> <td align="left" colspan="1" rowspan="1">73% (66 to 79)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">3447</td> <td align="left" colspan="1" rowspan="1">34</td> <td align="left" colspan="1" rowspan="1">0·23 (0·16 to 0·32)</td> <td align="left" colspan="1" rowspan="1">0·31 (0·22 to 0·44)</td> <td align="left" colspan="1" rowspan="1">0·19 (0·13 to 0·28)</td> <td align="left" colspan="1" rowspan="1">81% (72 to 87)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">1666</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">0·15 (0·08 to 0·26)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·12 to 0·39)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·06 to 0·25)</td> <td align="left" colspan="1" rowspan="1">88% (75 to 94)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">530</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·04 (0·01 to 0·29)</td> <td align="left" colspan="1" rowspan="1">0·06 (0·01 to 0·44)</td> <td align="left" colspan="1" rowspan="1">0·03 (0·00 to 0·37)</td> <td align="left" colspan="1" rowspan="1">97% (63 to 100)</td> </tr> <tr> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">51</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·44 (0·06 to 3·10)</td> <td align="left" colspan="1" rowspan="1">0·68 (0·10 to 4·87)</td> <td align="left" colspan="1" rowspan="1">0·41 (0·04 to 3·96)</td> <td align="left" colspan="1" rowspan="1">59% (−296 to 96)</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <div class="tw-foot p"> <div class="fn" id="fn7"><p>Poisson regression was used to provide all adjusted estimates. Individuals who had previously tested positive were excluded. RR=rate ratios. NA=not applicable. rtPCR=real-time reverse-transcription-PCR.</p></div> <div class="fn" id="tbl2fn1"> <sup>*</sup><p class="display-inline" id="cenpara40">Adjusted for age.</p> </div> <div class="fn" id="tbl2fn2"> <sup>†</sup><p class="display-inline" id="cenpara50">Adjusted for time (in weeks), age, sex, Scottish Index of Multiple Deprivation, number of rtPCR tests before vaccination, and number of underlying medical conditions.</p> </div> <div class="fn" id="tbl2fn3"> <sup>‡</sup><p class="display-inline" id="cenpara60">Adjusted for time (in weeks), age, sex, Scottish Index of Multiple Deprivation, number of rtPCR tests before vaccination, number of underlying medical conditions, and inverse propensity of being vaccinated.</p> </div> <div class="fn" id="tbl2fn4"> <sup>§</sup><p class="display-inline" id="cenpara70">Any effects observed in less than 14 days are mainly due to vaccine programme effects.</p> </div> </div></section><p id="para300">Similar findings were observed in a pooled analysis for both vaccines against COVID-19 hospital admissions stratified by age group (<a href="#tbl3" class="usa-link">table 3</a>). At 28–34 days after vaccination, the vaccine effect estimate for those aged 18–64 years was 92% (95% CI 82–97) and for those aged 65–79 years was 93% (73–98). Vaccine effect for those aged 80 years and older at 28–34 days was 83% (95% CI 72–89).</p> <section class="tw xbox font-sm" id="tbl3"><h3 class="obj_head">Table 3.</h3> <div class="caption p"><p>COVID-19 hospital admissions and days post-vaccination by age group and vaccination status and type</p></div> <div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"> <thead><tr> <th colspan="1" rowspan="1"></th> <th colspan="1" rowspan="1"></th> <th align="left" colspan="1" rowspan="1"><strong>Person-years</strong></th> <th align="left" colspan="1" rowspan="1"><strong>Number of events</strong></th> <th align="left" colspan="1" rowspan="1"> <strong>Age-adjusted RRs (95% CI)</strong><a href="#tbl3fn1" class="usa-link"><sup>*</sup></a> </th> <th align="left" colspan="1" rowspan="1"> <strong>Full-adjusted RRs (95% CI)</strong><a href="#tbl3fn2" class="usa-link"><sup>†</sup></a> </th> <th align="left" colspan="1" rowspan="1"> <strong>Full and inverse propensity weighting adjusted RRs (95% CI)</strong><a href="#tbl3fn3" class="usa-link"><sup>‡</sup></a> </th> <th align="left" colspan="1" rowspan="1"><strong>Vaccine programme effect (95% CI)</strong></th> </tr></thead> <tbody> <tr><td colspan="8" align="left" rowspan="1"><strong>Vaccinated overall</strong></td></tr> <tr><td colspan="8" align="left" rowspan="1">18–64 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">66 1 060</td> <td align="left" colspan="1" rowspan="1">3442</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">6720</td> <td align="left" colspan="1" rowspan="1">18</td> <td align="left" colspan="1" rowspan="1">0·40 (0·25 to 0·64)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·18 to 0·46)</td> <td align="left" colspan="1" rowspan="1">0·38 (0·29 to 0·50)</td> <td align="left" colspan="1" rowspan="1">62% (50 to 71)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">6667</td> <td align="left" colspan="1" rowspan="1">55</td> <td align="left" colspan="1" rowspan="1">1·29 (0·99 to 1·69)</td> <td align="left" colspan="1" rowspan="1">0·88 (0·66 to 1·16)</td> <td align="left" colspan="1" rowspan="1">1·10 (0·93 to 1·31)</td> <td align="left" colspan="1" rowspan="1">−10% (−31 to 7)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">5458</td> <td align="left" colspan="1" rowspan="1">25</td> <td align="left" colspan="1" rowspan="1">0·77 (0·52 to 1·14)</td> <td align="left" colspan="1" rowspan="1">0·49 (0·33 to 0·74)</td> <td align="left" colspan="1" rowspan="1">0·58 (0·45 to 0·75)</td> <td align="left" colspan="1" rowspan="1">42% (25 to 55)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">4769</td> <td align="left" colspan="1" rowspan="1">12</td> <td align="left" colspan="1" rowspan="1">0·43 (0·24 to 0·76)</td> <td align="left" colspan="1" rowspan="1">0·27 (0·15 to 0·49)</td> <td align="left" colspan="1" rowspan="1">0·38 (0·27 to 0·54)</td> <td align="left" colspan="1" rowspan="1">62% (46 to 73)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">3859</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·13 (0·04 to 0·41)</td> <td align="left" colspan="1" rowspan="1">0·09 (0·03 to 0·27)</td> <td align="left" colspan="1" rowspan="1">0·08 (0·03 to 0·18)</td> <td align="left" colspan="1" rowspan="1">92% (82 to 97)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">2797</td> <td align="left" colspan="1" rowspan="1">7</td> <td align="left" colspan="1" rowspan="1">0·43 (0·20 to 0·90)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·12 to 0·56)</td> <td align="left" colspan="1" rowspan="1">0·40 (0·25 to 0·62)</td> <td align="left" colspan="1" rowspan="1">60% (38 to 75)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">5166</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">0·37 (0·20 to 0·66)</td> <td align="left" colspan="1" rowspan="1">0·24 (0·13 to 0·45)</td> <td align="left" colspan="1" rowspan="1">0·35 (0·24 to 0·51)</td> <td align="left" colspan="1" rowspan="1">65% (49 to 76)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">65–79 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">132 254</td> <td align="left" colspan="1" rowspan="1">2449</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">9598</td> <td align="left" colspan="1" rowspan="1">42</td> <td align="left" colspan="1" rowspan="1">0·23 (0·17 to 0·31)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·19 to 0·35)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·08 to 0·17)</td> <td align="left" colspan="1" rowspan="1">88% (83 to 92)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">9148</td> <td align="left" colspan="1" rowspan="1">75</td> <td align="left" colspan="1" rowspan="1">0·44 (0·35 to 0·55)</td> <td align="left" colspan="1" rowspan="1">0·64 (0·50 to 0·82)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·20 to 0·35)</td> <td align="left" colspan="1" rowspan="1">74% (65 to 80)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">4219</td> <td align="left" colspan="1" rowspan="1">40</td> <td align="left" colspan="1" rowspan="1">0·46 (0·34 to 0·63)</td> <td align="left" colspan="1" rowspan="1">0·60 (0·43 to 0·83)</td> <td align="left" colspan="1" rowspan="1">0·25 (0·17 to 0·36)</td> <td align="left" colspan="1" rowspan="1">75% (64 to 83)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">1179</td> <td align="left" colspan="1" rowspan="1">15</td> <td align="left" colspan="1" rowspan="1">0·56 (0·34 to 0·94)</td> <td align="left" colspan="1" rowspan="1">0·47 (0·28 to 0·79)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·11 to 0·39)</td> <td align="left" colspan="1" rowspan="1">79% (61 to 89)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">498</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·28 (0·09 to 0·86)</td> <td align="left" colspan="1" rowspan="1">0·16 (0·05 to 0·50)</td> <td align="left" colspan="1" rowspan="1">0·07 (0·02 to 0·27)</td> <td align="left" colspan="1" rowspan="1">93% (73 to 98)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">242</td> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">1·03 (0·43 to 2·48)</td> <td align="left" colspan="1" rowspan="1">0·36 (0·14 to 0·91)</td> <td align="left" colspan="1" rowspan="1">0·16 (0·05 to 0·49)</td> <td align="left" colspan="1" rowspan="1">84% (51 to 95)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">334</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">1·82 (1·00 to 3·28)</td> <td align="left" colspan="1" rowspan="1">0·62 (0·34 to 1·15)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·13 to 0·58)</td> <td align="left" colspan="1" rowspan="1">72% (42 to 87)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">≥80 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">38 439</td> <td align="left" colspan="1" rowspan="1">1807</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">3072</td> <td align="left" colspan="1" rowspan="1">96</td> <td align="left" colspan="1" rowspan="1">0·68 (0·55 to 0·83)</td> <td align="left" colspan="1" rowspan="1">0·44 (0·36 to 0·55)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·20 to 0·32)</td> <td align="left" colspan="1" rowspan="1">74% (68 to 80)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">3876</td> <td align="left" colspan="1" rowspan="1">128</td> <td align="left" colspan="1" rowspan="1">0·73 (0·61 to 0·88)</td> <td align="left" colspan="1" rowspan="1">0·63 (0·52 to 0·77)</td> <td align="left" colspan="1" rowspan="1">0·34 (0·27 to 0·41)</td> <td align="left" colspan="1" rowspan="1">66% (59 to 73)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">3749</td> <td align="left" colspan="1" rowspan="1">89</td> <td align="left" colspan="1" rowspan="1">0·53 (0·43 to 0·65)</td> <td align="left" colspan="1" rowspan="1">0·54 (0·43 to 0·68)</td> <td align="left" colspan="1" rowspan="1">0·31 (0·24 to 0·39)</td> <td align="left" colspan="1" rowspan="1">69% (61 to 76)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">3172</td> <td align="left" colspan="1" rowspan="1">45</td> <td align="left" colspan="1" rowspan="1">0·32 (0·23 to 0·42)</td> <td align="left" colspan="1" rowspan="1">0·35 (0·26 to 0·49)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·15 to 0·30)</td> <td align="left" colspan="1" rowspan="1">79% (70 to 85)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">1894</td> <td align="left" colspan="1" rowspan="1">24</td> <td align="left" colspan="1" rowspan="1">0·28 (0·18 to 0·41)</td> <td align="left" colspan="1" rowspan="1">0·30 (0·19 to 0·46)</td> <td align="left" colspan="1" rowspan="1">0·17 (0·11 to 0·28)</td> <td align="left" colspan="1" rowspan="1">83% (72 to 89)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">782</td> <td align="left" colspan="1" rowspan="1">9</td> <td align="left" colspan="1" rowspan="1">0·24 (0·13 to 0·47)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·11 to 0·41)</td> <td align="left" colspan="1" rowspan="1">0·13 (0·06 to 0·27)</td> <td align="left" colspan="1" rowspan="1">87% (73 to 94)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">548</td> <td align="left" colspan="1" rowspan="1">10</td> <td align="left" colspan="1" rowspan="1">0·37 (0·20 to 0·69)</td> <td align="left" colspan="1" rowspan="1">0·24 (0·13 to 0·46)</td> <td align="left" colspan="1" rowspan="1">0·15 (0·07 to 0·32)</td> <td align="left" colspan="1" rowspan="1">85% (68 to 93)</td> </tr> <tr><td colspan="8" align="left" rowspan="1"><strong>BNT162b2 (Pfizer–BioNTech)</strong></td></tr> <tr><td colspan="8" align="left" rowspan="1">18–64 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">642 027</td> <td align="left" colspan="1" rowspan="1">3277</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">5157</td> <td align="left" colspan="1" rowspan="1">9</td> <td align="left" colspan="1" rowspan="1">0·28 (0·14 to 0·53)</td> <td align="left" colspan="1" rowspan="1">0·18 (0·09 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·22 (0·15 to 0·34)</td> <td align="left" colspan="1" rowspan="1">78% (66 to 85)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">5757</td> <td align="left" colspan="1" rowspan="1">46</td> <td align="left" colspan="1" rowspan="1">1·30 (0·97 to 1·73)</td> <td align="left" colspan="1" rowspan="1">0·84 (0·62 to 1·14)</td> <td align="left" colspan="1" rowspan="1">1·06 (0·88 to 1·27)</td> <td align="left" colspan="1" rowspan="1">−6% (−27 to 12)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">5141</td> <td align="left" colspan="1" rowspan="1">24</td> <td align="left" colspan="1" rowspan="1">0·79 (0·53 to 1·19)</td> <td align="left" colspan="1" rowspan="1">0·49 (0·32 to 0·74)</td> <td align="left" colspan="1" rowspan="1">0·58 (0·44 to 0·75)</td> <td align="left" colspan="1" rowspan="1">42% (25 to 56)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">4663</td> <td align="left" colspan="1" rowspan="1">12</td> <td align="left" colspan="1" rowspan="1">0·44 (0·25 to 0·78)</td> <td align="left" colspan="1" rowspan="1">0·27 (0·15 to 0·48)</td> <td align="left" colspan="1" rowspan="1">0·37 (0·26 to 0·53)</td> <td align="left" colspan="1" rowspan="1">63% (47 to 74)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">3804</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·14 (0·04 to 0·42)</td> <td align="left" colspan="1" rowspan="1">0·08 (0·03 to 0·27)</td> <td align="left" colspan="1" rowspan="1">0·08 (0·03 to 0·18)</td> <td align="left" colspan="1" rowspan="1">92% (82 to 97)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">2773</td> <td align="left" colspan="1" rowspan="1">7</td> <td align="left" colspan="1" rowspan="1">0·43 (0·21 to 0·91)</td> <td align="left" colspan="1" rowspan="1">0·25 (0·11 to 0·54)</td> <td align="left" colspan="1" rowspan="1">0·37 (0·24 to 0·59)</td> <td align="left" colspan="1" rowspan="1">63% (41 to 76)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">5161</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">0·37 (0·20 to 0·67)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·12 to 0·42)</td> <td align="left" colspan="1" rowspan="1">0·32 (0·22 to 0·47)</td> <td align="left" colspan="1" rowspan="1">68% (53 to 78)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">65–79 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">76 418</td> <td align="left" colspan="1" rowspan="1">1994</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">4487</td> <td align="left" colspan="1" rowspan="1">13</td> <td align="left" colspan="1" rowspan="1">0·11 (0·07 to 0·19)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·07 to 0·20)</td> <td align="left" colspan="1" rowspan="1">0·07 (0·03 to 0·13)</td> <td align="left" colspan="1" rowspan="1">93% (87 to 97)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">4580</td> <td align="left" colspan="1" rowspan="1">39</td> <td align="left" colspan="1" rowspan="1">0·33 (0·24 to 0·46)</td> <td align="left" colspan="1" rowspan="1">0·42 (0·30 to 0·58)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·15 to 0·34)</td> <td align="left" colspan="1" rowspan="1">77% (66 to 85)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">1904</td> <td align="left" colspan="1" rowspan="1">21</td> <td align="left" colspan="1" rowspan="1">0·38 (0·25 to 0·59)</td> <td align="left" colspan="1" rowspan="1">0·36 (0·23 to 0·56)</td> <td align="left" colspan="1" rowspan="1">0·20 (0·12 to 0·34)</td> <td align="left" colspan="1" rowspan="1">80% (66 to 88)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">399</td> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">0·40 (0·17 to 0·97)</td> <td align="left" colspan="1" rowspan="1">0·14 (0·06 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·09 (0·03 to 0·27)</td> <td align="left" colspan="1" rowspan="1">91% (73 to 97)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">278</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·36 (0·11 to 1·10)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·04 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·07 (0·02 to 0·27)</td> <td align="left" colspan="1" rowspan="1">93% (73 to 98)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">188</td> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">0·91 (0·38 to 2·20)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·09 to 0·58)</td> <td align="left" colspan="1" rowspan="1">0·14 (0·05 to 0·43)</td> <td align="left" colspan="1" rowspan="1">86% (57 to 95)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">329</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">1·20 (0·66 to 2·17)</td> <td align="left" colspan="1" rowspan="1">0·38 (0·21 to 0·71)</td> <td align="left" colspan="1" rowspan="1">0·24 (0·12 to 0·50)</td> <td align="left" colspan="1" rowspan="1">76% (50 to 88)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">≥80 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">15 963</td> <td align="left" colspan="1" rowspan="1">1400</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">497</td> <td align="left" colspan="1" rowspan="1">12</td> <td align="left" colspan="1" rowspan="1">0·27 (0·16 to 0·48)</td> <td align="left" colspan="1" rowspan="1">0·14 (0·08 to 0·24)</td> <td align="left" colspan="1" rowspan="1">0·11 (0·06 to 0·21)</td> <td align="left" colspan="1" rowspan="1">89% (79 to 94)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">654</td> <td align="left" colspan="1" rowspan="1">34</td> <td align="left" colspan="1" rowspan="1">0·60 (0·43 to 0·85)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·20 to 0·40)</td> <td align="left" colspan="1" rowspan="1">0·18 (0·12 to 0·27)</td> <td align="left" colspan="1" rowspan="1">82% (73 to 88)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">640</td> <td align="left" colspan="1" rowspan="1">26</td> <td align="left" colspan="1" rowspan="1">0·47 (0·32 to 0·70)</td> <td align="left" colspan="1" rowspan="1">0·25 (0·17 to 0·37)</td> <td align="left" colspan="1" rowspan="1">0·15 (0·10 to 0·24)</td> <td align="left" colspan="1" rowspan="1">85% (76 to 90)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">611</td> <td align="left" colspan="1" rowspan="1">21</td> <td align="left" colspan="1" rowspan="1">0·40 (0·26 to 0·62)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·15 to 0·36)</td> <td align="left" colspan="1" rowspan="1">0·15 (0·09 to 0·25)</td> <td align="left" colspan="1" rowspan="1">85% (75 to 91)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">503</td> <td align="left" colspan="1" rowspan="1">13</td> <td align="left" colspan="1" rowspan="1">0·30 (0·17 to 0·52)</td> <td align="left" colspan="1" rowspan="1">0·19 (0·11 to 0·34)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·06 to 0·24)</td> <td align="left" colspan="1" rowspan="1">88% (76 to 94)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">331</td> <td align="left" colspan="1" rowspan="1">8</td> <td align="left" colspan="1" rowspan="1">0·28 (0·14 to 0·56)</td> <td align="left" colspan="1" rowspan="1">0·18 (0·09 to 0·38)</td> <td align="left" colspan="1" rowspan="1">0·13 (0·06 to 0·30)</td> <td align="left" colspan="1" rowspan="1">87% (70 to 94)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">506</td> <td align="left" colspan="1" rowspan="1">9</td> <td align="left" colspan="1" rowspan="1">0·21 (0·11 to 0·40)</td> <td align="left" colspan="1" rowspan="1">0·22 (0·11 to 0·43)</td> <td align="left" colspan="1" rowspan="1">0·15 (0·07 to 0·34)</td> <td align="left" colspan="1" rowspan="1">85% (66 to 93)</td> </tr> <tr><td colspan="8" align="left" rowspan="1"><strong>ChAdOx1 (Oxford–AstraZeneca)</strong></td></tr> <tr><td colspan="8" align="left" rowspan="1">18–64 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">626 849</td> <td align="left" colspan="1" rowspan="1">3293</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">1473</td> <td align="left" colspan="1" rowspan="1">9</td> <td align="left" colspan="1" rowspan="1">0·72 (0·37 to 1·39)</td> <td align="left" colspan="1" rowspan="1">0·52 (0·26 to 1·02)</td> <td align="left" colspan="1" rowspan="1">0·82 (0·56 to 1·20)</td> <td align="left" colspan="1" rowspan="1">18% (−20 to 44)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">910</td> <td align="left" colspan="1" rowspan="1">9</td> <td align="left" colspan="1" rowspan="1">1·20 (0·62 to 2·30)</td> <td align="left" colspan="1" rowspan="1">0·81 (0·41 to 1·58)</td> <td align="left" colspan="1" rowspan="1">0·99 (0·64 to 1·52)</td> <td align="left" colspan="1" rowspan="1">1% (−52 to 36)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">317</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·40 (0·06 to 2·87)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·04 to 2·03)</td> <td align="left" colspan="1" rowspan="1">0·25 (0·06 to 1·06)</td> <td align="left" colspan="1" rowspan="1">75% (−6 to 94)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">105</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">55</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">24</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">65–79 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">81 523</td> <td align="left" colspan="1" rowspan="1">2194</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">4761</td> <td align="left" colspan="1" rowspan="1">29</td> <td align="left" colspan="1" rowspan="1">0·22 (0·15 to 0·32)</td> <td align="left" colspan="1" rowspan="1">0·24 (0·16 to 0·35)</td> <td align="left" colspan="1" rowspan="1">0·12 (0·08 to 0·19)</td> <td align="left" colspan="1" rowspan="1">88% (81 to 92)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">4567</td> <td align="left" colspan="1" rowspan="1">36</td> <td align="left" colspan="1" rowspan="1">0·28 (0·20 to 0·39)</td> <td align="left" colspan="1" rowspan="1">0·45 (0·31 to 0·63)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·14 to 0·31)</td> <td align="left" colspan="1" rowspan="1">79% (69 to 86)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">2316</td> <td align="left" colspan="1" rowspan="1">19</td> <td align="left" colspan="1" rowspan="1">0·28 (0·18 to 0·44)</td> <td align="left" colspan="1" rowspan="1">0·46 (0·29 to 0·74)</td> <td align="left" colspan="1" rowspan="1">0·21 (0·12 to 0·37)</td> <td align="left" colspan="1" rowspan="1">79% (63 to 88)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">780</td> <td align="left" colspan="1" rowspan="1">10</td> <td align="left" colspan="1" rowspan="1">0·42 (0·22 to 0·78)</td> <td align="left" colspan="1" rowspan="1">0·69 (0·37 to 1·32)</td> <td align="left" colspan="1" rowspan="1">0·32 (0·15 to 0·69)</td> <td align="left" colspan="1" rowspan="1">68% (31 to 85)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">220</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">55</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">5</td> <td align="left" colspan="1" rowspan="1">0</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">0·00 (0·00 to NA)</td> <td align="left" colspan="1" rowspan="1">100% (NA to 100)</td> </tr> <tr><td colspan="8" align="left" rowspan="1">≥80 years</td></tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Unvaccinated</td> <td align="left" colspan="1" rowspan="1">35 266</td> <td align="left" colspan="1" rowspan="1">1765</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">1 (ref)</td> <td align="left" colspan="1" rowspan="1">0</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (0–6 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">2493</td> <td align="left" colspan="1" rowspan="1">84</td> <td align="left" colspan="1" rowspan="1">0·69 (0·56 to 0·86)</td> <td align="left" colspan="1" rowspan="1">0·50 (0·40 to 0·63)</td> <td align="left" colspan="1" rowspan="1">0·28 (0·22 to 0·36)</td> <td align="left" colspan="1" rowspan="1">72% (64 to 78)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (7–13 days)<a href="#tbl3fn4" class="usa-link"><sup>§</sup></a> </td> <td align="left" colspan="1" rowspan="1">3221</td> <td align="left" colspan="1" rowspan="1">94</td> <td align="left" colspan="1" rowspan="1">0·61 (0·50 to 0·75)</td> <td align="left" colspan="1" rowspan="1">0·64 (0·51 to 0·81)</td> <td align="left" colspan="1" rowspan="1">0·37 (0·29 to 0·47)</td> <td align="left" colspan="1" rowspan="1">63% (53 to 71)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (14–20 days)</td> <td align="left" colspan="1" rowspan="1">3109</td> <td align="left" colspan="1" rowspan="1">63</td> <td align="left" colspan="1" rowspan="1">0·43 (0·33 to 0·55)</td> <td align="left" colspan="1" rowspan="1">0·56 (0·42 to 0·74)</td> <td align="left" colspan="1" rowspan="1">0·37 (0·28 to 0·50)</td> <td align="left" colspan="1" rowspan="1">63% (50 to 72)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (21–27 days)</td> <td align="left" colspan="1" rowspan="1">2561</td> <td align="left" colspan="1" rowspan="1">24</td> <td align="left" colspan="1" rowspan="1">0·20 (0·13 to 0·29)</td> <td align="left" colspan="1" rowspan="1">0·30 (0·19 to 0·47)</td> <td align="left" colspan="1" rowspan="1">0·23 (0·14 to 0·37)</td> <td align="left" colspan="1" rowspan="1">77% (63 to 86)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (28–34 days)</td> <td align="left" colspan="1" rowspan="1">1391</td> <td align="left" colspan="1" rowspan="1">11</td> <td align="left" colspan="1" rowspan="1">0·16 (0·09 to 0·30)</td> <td align="left" colspan="1" rowspan="1">0·26 (0·14 to 0·50)</td> <td align="left" colspan="1" rowspan="1">0·19 (0·09 to 0·40)</td> <td align="left" colspan="1" rowspan="1">81% (60 to 91)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (35–41 days)</td> <td align="left" colspan="1" rowspan="1">451</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·04 (0·01 to 0·32)</td> <td align="left" colspan="1" rowspan="1">0·07 (0·01 to 0·53)</td> <td align="left" colspan="1" rowspan="1">0·05 (0·00 to 0·56)</td> <td align="left" colspan="1" rowspan="1">95% (44 to 100)</td> </tr> <tr> <td colspan="1" rowspan="1"></td> <td align="left" colspan="1" rowspan="1">Vaccine dose 1 (42+ days)</td> <td align="left" colspan="1" rowspan="1">42</td> <td align="left" colspan="1" rowspan="1">≤5</td> <td align="left" colspan="1" rowspan="1">0·48 (0·07 to 3·39)</td> <td align="left" colspan="1" rowspan="1">0·84 (0·12 to 6·03)</td> <td align="left" colspan="1" rowspan="1">0·64 (0·07 to 6·24)</td> <td align="left" colspan="1" rowspan="1">36% (−524 to 93)</td> </tr> </tbody> </table></div> <div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <div class="tw-foot p"> <div class="fn" id="fn12"><p>Poisson regression was used to provide all adjusted estimates. Individuals who had previously tested positive were excluded. RR=rate ratios. NA=not applicable. rtPCR=real-time reverse-transcription-PCR.</p></div> <div class="fn" id="tbl3fn1"> <sup>*</sup><p class="display-inline" id="cenpara80">Adjusted for age.</p> </div> <div class="fn" id="tbl3fn2"> <sup>†</sup><p class="display-inline" id="cenpara90">Adjusted for time (in weeks), age, sex, Scottish Index of Multiple Deprivation, number of rtPCR tests before vaccination, and number of underlying medical conditions.</p> </div> <div class="fn" id="tbl3fn3"> <sup>‡</sup><p class="display-inline" id="cenpara100">Adjusted for time (in weeks), age, sex, Scottish Index of Multiple Deprivation, number of rtPCR tests before vaccination, number of underlying medical conditions, and inverse propensity of being vaccinated.</p> </div> <div class="fn" id="tbl3fn4"> <sup>§</sup><p class="display-inline" id="cenpara110">Any effects observed in less than 14 days are mainly due to vaccine programme effects.</p> </div> </div></section><p id="para310">Among those aged 80 years and older at 28–34 days post-vaccination, vaccine effect against COVID-19 hospital admission for those who received the first dose of the BNT162b2 mRNA vaccine was 88% (95% CI 76–94), and for ChAdOx1 was 81% (60–91; <a href="#tbl3" class="usa-link">table 3</a>).</p> <p id="para320">The falsification analysis involving shifting the vaccination date back 2 months to a period when vaccination could not have had an effect showed no difference between the vaccinated and unvaccinated groups over the whole follow-up period (<a href="#sec1" class="usa-link">appendix pp 6–9</a>).</p></section><section id="cesec80"><h2 class="pmc_sec_title">Discussion</h2> <p id="para330">This national prospective cohort study comprising almost the entire Scottish population found that the mass roll-out of the first doses of the BNT162b2 mRNA or ChAdOx1 vaccines was associated with protection against COVID-19 admission to hospital. A vaccine effect of 91% for the BNT162b2 mRNA vaccine and 88% for the ChAdOx1 vaccine were found against COVID-19 hospital admissions at 28–34 days after vaccination. In the oldest age group (≥80 years), on the basis of a pooled analysis for both vaccines, we observed a vaccine effect of 83% against COVID-19 hospital admissions at this same timepoint. For the same age group and at the same time, a vaccine effect of 88% was found for the BNT162b2 mRNA vaccine, and 81% for the ChAdOx1 vaccine.</p> <p id="para340">A study from Israel (Clalit Health Services) has reported on the vaccine effect of BNT162b2 mRNA. An analysis of data on more than 1·1 million individuals showed that after the first dose of vaccination, an effect of 74% was found 14–20 days after immunisation and an effect of 78% was found 21–27 days after immunisation against SARS-CoV-2 hospital admission.<a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a> Public Health England has reported that single dose vaccine effects against hospital admission for BNT162b2 mRNA and ChAdOx1 were 80%.<a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a> Complementary to these studies, we found a similar vaccine effect against COVID-19 hospital admission for the BNT162b2 mRNA and ChAdOx1 vaccines after a single dose.</p> <p id="para350">This is, to our knowledge, the first national population-level study assessing the programme effect of currently licensed COVID-19 vaccines on a severe COVID-19 outcome. Our study has several strengths. We developed a national linked dataset and have created a platform that allowed rapid access to and analysis of data on vaccination status and medical condition status from routinely collected electronic health record data and national databases.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>, </sup><a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a> This study is therefore less susceptible to recall or misclassification bias than are studies of samples of the population. The use of a large population aided study power, facilitating estimation of vaccine effect in multiple age groups and time intervals after the first dose of the vaccination. We are likely to have excellent generalisability across the UK and potentially across other countries with similar national vaccination programmes using these same vaccines.</p> <p id="para360">Our study also had several limitations. First, we estimated vaccine effect against COVID-19 hospital admission. However, there are other outcomes of interest, including general practice and accident and emergency department consultations, intensive care unit admissions, deaths, and rate of secondary SARS-CoV-2 infections within households, in addition to maternal and neonatal outcomes. We did not estimate vaccine effect against these outcomes. Second, although our vaccine effect estimates were adjusted for potential confounders and despite the reassurance provided by the falsification of exposure sensitivity analysis, unmeasured confounders could still have influenced our estimates. Furthermore, given the limited period of follow-up, we did not attempt to identify a peak vaccine effect estimate for each vaccine. Finally, we were unable to compare vaccine effects between the two vaccines; this is primarily because of the non-experimental design of our study and because the target population differed between vaccines in this initial roll-out period.</p> <p id="para370">Additional non-vaccine effects on hospital admissions could have resulted in potential bias. These included new lockdowns and changes from tier restrictions to full lockdowns across Scotland. However, partial lockdowns were present before the start of the vaccination programme and a full lockdown for the entire population—including those vaccinated—began on Dec 26, 2020, and was reinforced on Jan 5, 2021. Overall, data available from UK serial surveys to the Scottish Government and Public Health Scotland suggested good compliance with these partial and full lockdowns,<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> which are unlikely to have been operating differentially between vaccinated and unvaccinated people with the exception of health-care workers and social-care workers because they were considered essential workers. We adjusted for time to adjust for any impact on the effect of these interventions and the course of the pandemic on our estimates of vaccine effects. Other limitations of our study include the ChAdOx1 vaccine being predominantly used in older people and available only from Jan 4, 2021, giving less time for follow-up. Finally, although we had large population samples, an insufficient number of people had received the second dose of the vaccines to reliably study vaccine effect after receiving a full course of vaccination. However, the vaccine effect of a single dose is of policy interest when considering the ongoing debate over whether to defer a second dose to allow more rapid population coverage.</p> <p id="para380">There are likely to be mechanisms that have contributed mainly to the early (<14 days) effects we observed in most age groups. We believe that these effects might be due to the way in which the Scottish vaccination programme was conceptualised and operationalised. Notably, individuals who were prioritised for vaccination received a written invitation to attend for a scheduled appointment about 14 days before the vaccination date. However, they were asked to reschedule their appointment if they had recently (within the past 4 weeks) had symptoms suggestive of COVID-19, a positive COVID-19 test, or were self-isolating. They also received written advice emphasising the importance of behavioural measures to minimise the risk of contracting the SARS-CoV-2 virus. Furthermore, at the time of the vaccination, additional checks were made to ensure that they had not recently had suggested or confirmed COVID-19 and the behavioural advice was reinforced both verbally and with an additional leaflet. Possible explanations for these early effects therefore include: (1) a time-limited healthy vaccinated bias arising from the instruction that those who recently had COVID-19, tested positive, or were self-isolating were asked to defer vaccination;<a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a> (2) reinforcement of the importance of following behavioural advice before and during vaccination;<a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a><sup>, </sup><a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a> (3) early responses in those who were not SARS-CoV-2 naive (>10% of the Scottish population);<a href="#bib21" class="usa-link" aria-describedby="bib21"><sup>21</sup></a><sup>, </sup><a href="#bib22" class="usa-link" aria-describedby="bib22"><sup>22</sup></a> and (4) a time-independent healthy vaccinated bias in which vaccines might not have been offered to or were declined by the most frail.<a href="#bib23" class="usa-link" aria-describedby="bib23"><sup>23</sup></a> We attempted to adjust for the time-independent healthy vaccinated effect using a functional variable, namely dementia.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> We had hoped to use additional functional variables such as nursing home residency and need for home help, but these variables were not available to us.</p> <p id="para390">By contrast, the later observed effects (>14 days) are much more likely to be mainly driven by traditional vaccine effects because the impact of the vaccine programme effects are likely to have waned by this timepoint. However, our main timepoint of interest, namely 28–34 days, probably reflects the true effects of the vaccine.</p> <p id="para400">Monitoring the effect of currently licensed vaccines in the general population needs to be continued in Scotland and the other UK nations, especially in high-risk subgroups such as those in care homes where more data will be needed to produce reliable vaccine effect estimates. Similarly, further monitoring is required to assess the effect of receiving two doses rather than one dose. Robust observational epidemiological studies should be carried out to measure the coverage of these newly introduced vaccines in relation to demographic and other population characteristics and to detect adverse events. These post-marketing observational studies will add value to the pre-licensure clinical trials as they can assess so-called real-life effects of the COVID-19 vaccines and the effect of the vaccination programme at a population level. We plan in due course to report on the effectiveness of the first dose on mortality and adverse events associated with the first dose. We also plan to report on any possible waning of the first-dose effects, on post-vaccine first-dose COVID-19 hospital admissions and deaths, and on second-dose effects.</p> <p id="para410">In summary, we provide national evidence that the roll-out of the first doses of the BNT162b2 mRNA and ChAdOx1 vaccines were associated with reductions in hospital admissions due to COVID-19 in high-risk adults in Scotland.</p></section><section id="cesec90"><h2 class="pmc_sec_title">Data sharing</h2> <p id="para440">A data dictionary covering the datasets used in this study can be found at <a href="https://github.com/EAVE-II/EAVE-II-data-dictionary" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EAVE-II/EAVE-II-data-dictionary</a>. All code used in this study is publicly available at <a href="https://github.com/EAVE-II/Covid-VE" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EAVE-II/Covid-VE</a>. The data used in this study are sensitive and will not be made publicly available.</p></section><section id="sec15"><h2 class="pmc_sec_title">Declaration of interests</h2> <p id="para450">AS and JMcM are members of the Scottish Government chief medical officer's COVID-19 Advisory Group. JMcM is a member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) and AS is a member of the NERVTAG Risk Stratification Subgroup. JMcM is a member of the Scientific Advisory Group on Emergencies (SAGE) and chairs the COVID Scottish National Incident Management Team and the Scientific Committee of the European Centre for Disease Prevention and Control-funded and WHO-funded IMOVE-COVID-19 group. CRS declares funding from the Medical Research Council, the National Institute of Health Research, Chief Scientist Office, and New Zealand Ministry for Business, Innovation and Employment and Health Research Council during the conduct of this study. SVK is co-chair of the Scottish Government's Expert Reference Group on COVID-19 and ethnicity; is a member of the SAGE subgroup on ethnicity; and acknowledges funding from a National Health Service Research Scotland Senior Clinical Fellowship, the Medical Research Council, and Chief Scientist Office. CR is a member of the Scottish Government chief medical officer's COVID-19 Advisory Group, Scientific Pandemic Influenza Group on Modelling, and Medicines and Healthcare products Regulatory Agency Vaccine Benefit and Risk Working Group. DB reports employment by Queen's University Belfast, Public Health Agency, and a secondment to Northern Ireland's Department of Health. SdL reports that he is the director of the Oxford-Royal College of General Practitioners Research and Surveillance Centre and that its principal funder is Public Health England. SdL has received funding through the University of Oxford for studies from AstraZeneca, Daiichi Sankyo, Eli Lilly, Sanofi, GSK, Merck Sharp & Dohme, Seqirus, and Takeda; and has been a member of advisory boards for influenza for Seqirus and Sanofi. FDRH reports that the University of Oxford received research funding from Her Majesty's Government for the ChadOx1 vaccine trial programme and entered a partnership with AstraZeneca for the manufacture and distribution of the vaccine. FDRH was not involved in these relationships. All other authors report no competing interests.</p></section><section id="ceack10" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2> <section id="sec17"><h3 class="pmc_sec_title">Acknowledgments</h3> <p>EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE—The Health Data Research Hub for Respiratory Health (MC_PC_19004), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and the Scottish Government's director-general of Health and Social Care. FDRH acknowledges part support from the National Institutes of Health Research (NIHR) School for Primary Care Research, the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford, and the NIHR Oxford Biomedical Research Centre. We thank Dave Kelly from Albasoft for his support with making primary care data available, and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, and Laura Gonzalez Rienda for their support with project management and administration. SVK acknowledges funding from an NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and Scottish Government Chief Scientist Office (SPHSU13).</p></section></section><section id="ack2" class="ack"><h2 class="pmc_sec_title">Contributors</h2> <p>AS, CRS, CR, LR, MW, and JM conceived this study. AS, CRS, EV, and CR commented on the paper, oversaw the analysis, and edited the final manuscript. EV, CRS, CR, TS, and SK led the writing of the paper. CR and EM cleaned, analysed, and verified the underlying data. All authors contributed to the study design. All authors contributed to drafting the paper and revised the manuscript for important intellectual content. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.</p></section><section id="sec1"><h2 class="pmc_sec_title">Supplementary Material</h2> <section class="sm xbox font-sm" id="ecomp10"><div class="caption p"><span>Supplementary appendix</span></div> <div class="media p"><div class="caption"> <a href="/articles/instance/8102466/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (479.4KB, pdf) </sup> </div></div></section></section><section id="bibl10" class="ref-list"><h2 class="pmc_sec_title">References</h2> <section id="bibl10_sec2"><ul class="ref-list font-sm" style="list-style-type:none"> <li id="bib1"> <span class="label">1.</span><cite>UK Government Coronavirus in the UK. 2021. <a href="https://coronavirus.data.gov.uk/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://coronavirus.data.gov.uk/</a></cite> </li> <li id="bib2"> <span class="label">2.</span><cite>Ramasamy MN, Minassian AM, Ewer KJ. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2020;396:1979–1993. doi: 10.1016/S0140-6736(20)32466-1.</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)32466-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7674972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33220855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&title=Safety%20and%20immunogenicity%20of%20ChAdOx1%20nCoV-19%20vaccine%20administered%20in%20a%20prime-boost%20regimen%20in%20young%20and%20old%20adults%20(COV002):%20a%20single-blind,%20randomised,%20controlled,%20phase%202/3%20trial&author=MN%20Ramasamy&author=AM%20Minassian&author=KJ%20Ewer&volume=396&publication_year=2020&pages=1979-1993&pmid=33220855&doi=10.1016/S0140-6736(20)32466-1&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib3"> <span class="label">3.</span><cite>UK Government Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020. 2021. <a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020</a></cite> </li> <li id="bib4"> <span class="label">4.</span><cite>Polack FP, Thomas SJ, Kitchin N. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl J Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577.</cite> [<a href="https://doi.org/10.1056/NEJMoa2034577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7745181/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&title=Safety%20and%20efficacy%20of%20the%20BNT162b2%20mRNA%20Covid-19%20vaccine&author=FP%20Polack&author=SJ%20Thomas&author=N%20Kitchin&volume=383&publication_year=2020&pages=2603-2615&pmid=33301246&doi=10.1056/NEJMoa2034577&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib5"> <span class="label">5.</span><cite>Voysey M, Clemens SAC, Madhi SA. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111. doi: 10.1016/S0140-6736(20)32661-1.</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)32661-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7723445/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33306989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&title=Safety%20and%20efficacy%20of%20the%20ChAdOx1%20nCoV-19%20vaccine%20(AZD1222)%20against%20SARS-CoV-2:%20an%20interim%20analysis%20of%20four%20randomised%20controlled%20trials%20in%20Brazil,%20South%20Africa,%20and%20the%20UK&author=M%20Voysey&author=SAC%20Clemens&author=SA%20Madhi&volume=397&publication_year=2021&pages=99-111&pmid=33306989&doi=10.1016/S0140-6736(20)32661-1&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib6"> <span class="label">6.</span><cite>Baden LR, El Sahly HM, Essink B. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389.</cite> [<a href="https://doi.org/10.1056/NEJMoa2035389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7787219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&title=Efficacy%20and%20safety%20of%20the%20mRNA-1273%20SARS-CoV-2%20vaccine&author=LR%20Baden&author=HM%20El%20Sahly&author=B%20Essink&volume=384&publication_year=2021&pages=403-416&pmid=33378609&doi=10.1056/NEJMoa2035389&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib7"> <span class="label">7.</span><cite>Lopalco PL, DeStefano F. The complementary roles of phase 3 trials and post-licensure surveillance in the evaluation of new vaccines. Vaccine. 2015;33:1541–1548. doi: 10.1016/j.vaccine.2014.10.047.</cite> [<a href="https://doi.org/10.1016/j.vaccine.2014.10.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4596394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25444788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&title=The%20complementary%20roles%20of%20phase%203%20trials%20and%20post-licensure%20surveillance%20in%20the%20evaluation%20of%20new%20vaccines&author=PL%20Lopalco&author=F%20DeStefano&volume=33&publication_year=2015&pages=1541-1548&pmid=25444788&doi=10.1016/j.vaccine.2014.10.047&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib8"> <span class="label">8.</span><cite>Simpson CR, Robertson C, Vasileiou E. Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data. BMJ Open. 2020;10 doi: 10.1136/bmjopen-2020-039097.</cite> [<a href="https://doi.org/10.1136/bmjopen-2020-039097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7311023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32565483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&title=Early%20pandemic%20evaluation%20and%20enhanced%20surveillance%20of%20COVID-19%20(EAVE%20II):%20protocol%20for%20an%20observational%20study%20using%20linked%20Scottish%20national%20data&author=CR%20Simpson&author=C%20Robertson&author=E%20Vasileiou&volume=10&publication_year=2020&pmid=32565483&doi=10.1136/bmjopen-2020-039097&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib9"> <span class="label">9.</span><cite>Benchimol EI, Smeeth L, Guttmann A. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12 doi: 10.1371/journal.pmed.1001885.</cite> [<a href="https://doi.org/10.1371/journal.pmed.1001885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4595218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26440803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Med&title=The%20REporting%20of%20studies%20Conducted%20using%20Observational%20Routinely-collected%20health%20Data%20(RECORD)%20statement&author=EI%20Benchimol&author=L%20Smeeth&author=A%20Guttmann&volume=12&publication_year=2015&pmid=26440803&doi=10.1371/journal.pmed.1001885&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib10"> <span class="label">10.</span><cite>National Services Scotland National Data Catalogue. Rapid preliminary inpatient data (RAPID) 2020. <a href="https://www.ndc.scot.nhs.uk/National-Datasets/data.asp?SubID=37" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ndc.scot.nhs.uk/National-Datasets/data.asp?SubID=37</a></cite> </li> <li id="bib11"> <span class="label">11.</span><cite>Turas Vaccination Management Tool. <a href="https://learn.nes.nhs.scot/42708/turas-vaccination-management-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://learn.nes.nhs.scot/42708/turas-vaccination-management-tool</a></cite> </li> <li id="bib12"> <span class="label">12.</span><cite>UK Government COVID-19 testing data: methodology note. 2020. <a href="https://www.gov.uk/government/publications/coronavirus-covid-19-testing-data-methodology/covid-19-testing-data-methodology-note" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.gov.uk/government/publications/coronavirus-covid-19-testing-data-methodology/covid-19-testing-data-methodology-note</a></cite> </li> <li id="bib13"> <span class="label">13.</span><cite>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399–424. doi: 10.1080/00273171.2011.568786.</cite> [<a href="https://doi.org/10.1080/00273171.2011.568786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3144483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21818162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Multivariate%20Behav%20Res&title=An%20introduction%20to%20propensity%20score%20methods%20for%20reducing%20the%20effects%20of%20confounding%20in%20observational%20studies&author=PC%20Austin&volume=46&publication_year=2011&pages=399-424&pmid=21818162&doi=10.1080/00273171.2011.568786&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib14"> <span class="label">14.</span><cite>Jackson LA, Jackson ML, Nelson JC. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35:337–344. doi: 10.1093/ije/dyi274.</cite> [<a href="https://doi.org/10.1093/ije/dyi274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16368725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Epidemiol&title=Evidence%20of%20bias%20in%20estimates%20of%20influenza%20vaccine%20effectiveness%20in%20seniors&author=LA%20Jackson&author=ML%20Jackson&author=JC%20Nelson&volume=35&publication_year=2006&pages=337-344&pmid=16368725&doi=10.1093/ije/dyi274&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib15"> <span class="label">15.</span><cite>Dagan N, Barda N, Kepten E. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. New Engl J Med. 2021 doi: 10.1056/NEJMoa2101765. published online Feb 24.</cite> [<a href="https://doi.org/10.1056/NEJMoa2101765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7944975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33626250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20Engl%20J%20Med&title=BNT162b2%20mRNA%20Covid-19%20vaccine%20in%20a%20nationwide%20mass%20vaccination%20setting&author=N%20Dagan&author=N%20Barda&author=E%20Kepten&publication_year=2021&pmid=33626250&doi=10.1056/NEJMoa2101765&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib16"> <span class="label">16.</span><cite>Bernal JL, Andrews N, Gower C. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. medRxiv. 2021 doi: 10.1101/2021.03.01.21252652. published online March 2. (preprint).</cite> [<a href="https://doi.org/10.1101/2021.03.01.21252652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Early%20effectiveness%20of%20COVID-19%20vaccination%20with%20BNT162b2%20mRNA%20vaccine%20and%20ChAdOx1%20adenovirus%20vector%20vaccine%20on%20symptomatic%20disease,%20hospitalisations%20and%20mortality%20in%20older%20adults%20in%20England&author=JL%20Bernal&author=N%20Andrews&author=C%20Gower&publication_year=2021&doi=10.1101/2021.03.01.21252652&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib17"> <span class="label">17.</span><cite>Simpson CR, Beever D, Challen K. The UK's pandemic influenza research portfolio: a model for future research on emerging infections. Lancet Infect Dis. 2019;19:e295–e300. doi: 10.1016/S1473-3099(18)30786-2.</cite> [<a href="https://doi.org/10.1016/S1473-3099(18)30786-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31006605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect%20Dis&title=The%20UK's%20pandemic%20influenza%20research%20portfolio:%20a%20model%20for%20future%20research%20on%20emerging%20infections&author=CR%20Simpson&author=D%20Beever&author=K%20Challen&volume=19&publication_year=2019&pages=e295-e300&pmid=31006605&doi=10.1016/S1473-3099(18)30786-2&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib18"> <span class="label">18.</span><cite>University College London Covid-19 social study. Results release 29. 2021. <a href="https://b6bdcb03-332c-4ff9-8b9d-28f9c957493a.filesusr.com/ugd/3d9db5_59d1b940054440bbb52a72b6bd0b0a06.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://b6bdcb03-332c-4ff9-8b9d-28f9c957493a.filesusr.com/ugd/3d9db5_59d1b940054440bbb52a72b6bd0b0a06.pdf</a></cite> </li> <li id="bib19"> <span class="label">19.</span><cite>Aran D. Estimating real-world COVID-19 vaccine effectiveness in Israel. medRxiv. 2021 doi: 10.1101/2021.02.05.21251139. published online Feb 11. (preprint).</cite> [<a href="https://doi.org/10.1101/2021.02.05.21251139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Estimating%20real-world%20COVID-19%20vaccine%20effectiveness%20in%20Israel&author=D%20Aran&publication_year=2021&doi=10.1101/2021.02.05.21251139&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib20"> <span class="label">20.</span><cite>Public Health England PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England. 2021. <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963532/COVID-19_vaccine_effectiveness_surveillance_report_February_2021_FINAL.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963532/COVID-19_vaccine_effectiveness_surveillance_report_February_2021_FINAL.pdf</a></cite> </li> <li id="bib21"> <span class="label">21.</span><cite>Krammer F, Srivastava K, the PARIS team. Simon V. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine. medRxiv. 2021 doi: 10.1101/2021.01.29.21250653. published online Feb 1. (preprint).</cite> [<a href="https://doi.org/10.1101/2021.01.29.21250653" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Robust%20spike%20antibody%20responses%20and%20increased%20reactogenicity%20in%20seropositive%20individuals%20after%20a%20single%20dose%20of%20SARS-CoV-2%20mRNA%20vaccine&author=F%20Krammer&author=K%20Srivastava&author=V%20Simon&publication_year=2021&doi=10.1101/2021.01.29.21250653&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib22"> <span class="label">22.</span><cite>Saadat S, Tehrani ZR, Logue J. Single dose vaccination in healthcare workers previously infected with SARS-CoV-2. medRxiv. 2021 doi: 10.1101/2021.01.30.21250843. published online Feb 1. (preprint).</cite> [<a href="https://doi.org/10.1101/2021.01.30.21250843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Single%20dose%20vaccination%20in%20healthcare%20workers%20previously%20infected%20with%20SARS-CoV-2&author=S%20Saadat&author=ZR%20Tehrani&author=J%20Logue&publication_year=2021&doi=10.1101/2021.01.30.21250843&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bib23"> <span class="label">23.</span><cite>Jackson LA, Nelson JC, Benson P. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35:345–352. doi: 10.1093/ije/dyi275.</cite> [<a href="https://doi.org/10.1093/ije/dyi275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16368724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Epidemiol&title=Functional%20status%20is%20a%20confounder%20of%20the%20association%20of%20influenza%20vaccine%20and%20risk%20of%20all%20cause%20mortality%20in%20seniors&author=LA%20Jackson&author=JC%20Nelson&author=P%20Benson&volume=35&publication_year=2006&pages=345-352&pmid=16368724&doi=10.1093/ije/dyi275&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> </ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2> <p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p> <section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3> <section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplementary appendix</span></div> <div class="media p"><div class="caption"> <a href="/articles/instance/8102466/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (479.4KB, pdf) </sup> </div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3> <p>A data dictionary covering the datasets used in this study can be found at <a href="https://github.com/EAVE-II/EAVE-II-data-dictionary" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EAVE-II/EAVE-II-data-dictionary</a>. All code used in this study is publicly available at <a href="https://github.com/EAVE-II/Covid-VE" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EAVE-II/Covid-VE</a>. The data used in this study are sensitive and will not be made publicly available.</p></section></section></section></section></article> </main> </div> </div> </div>  <div class="pmc-sidenav desktop:grid-col-4 display-flex"> <section class="pmc-sidenav__container" aria-label="Article resources and navigation"> <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled"> <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" /> </button> <div class="display-none desktop:display-block"> <section class="margin-top-4 desktop:margin-top-0"> <h2 class="margin-top-0">ACTIONS</h2> <ul class="usa-list usa-list--unstyled usa-list--actions"> <li> <a href="https://doi.org/10.1016/S0140-6736(21)00677-2" class="usa-button usa-button--outline width-24 font-xs usa-link--external padding-left-0 padding-right-0" target="_blank" rel="noreferrer noopener" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_desktop" > <span class="height-3 display-inline-flex flex-align-center">View on publisher site</span> </a> </li> <li> <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_desktop" data-all-citations-url="/resources/citations/8064669/" data-citation-style="nlm" data-download-format-link="/resources/citations/8064669/export/" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span> </button> </li> <li> <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_desktop" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8064669%2F%23open-collections-dialog" data-in-collections="false"> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1">Collections</span> </button> </li> <li class="pmc-permalink"> <button type="button" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_desktop" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8064669/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </section> </div> <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8064669/"> <h2 class="margin-top-0">RESOURCES</h2> <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-similar-articles" data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/articles/PMC8064669/" data-action-open="open_similar_articles" data-action-close="close_similar_articles" > Similar articles </button> </h3> <div id="resources-similar-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/similar-article-links/33901420/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-cited-by-other-articles" data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/articles/PMC8064669/" data-action-open="open_cited_by" data-action-close="close_cited_by" > Cited by other articles </button> </h3> <div id="resources-cited-by-other-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/cited-by-links/33901420/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-links-to-ncbi-databases" data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/articles/PMC8064669/" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link" > Links to NCBI Databases </button> </h3> <div id="resources-links-to-ncbi-databases" class="usa-accordion__content usa-prose" data-source-url="/resources/db-links/8064669/" > </div> </div> </section> <section class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4" data-title-text="On this page" data-title-heading-level="h2" data-scroll-offset="0" data-root-margin="-10% 0px -80% 0px" data-main-content-selector="main" data-threshold="1" hidden ></section> </section> </div> <div class="overlay" role="dialog" aria-label="Citation Dialog" hidden> <div class="dialog citation-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Cite</h2> <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto" tabindex="1"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="citation-text-block"> <div class="citation-text margin-bottom-2"></div> <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center"> <li> <button class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus" data-ga-category="save_share" data-ga-action="cite" data-ga-label="copy" tabindex="2"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span>Copy</span> </button> </li> <li> <a href="#" role="button" class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button" data-ga-category="save_share" data-ga-action="cite" data-ga-label="download" title="Download a file for external citation management software" tabindex="3"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> <span class="display-none mobile-lg:display-inline">Download .nbib</span> <span class="display-inline mobile-lg:display-none">.nbib</span> </a> </li> <li> <div class="display-inline-flex flex-align-center"> <label class="usa-label margin-top-0">Format:</label> <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" > <option data-style-url-name="ama" value="AMA" > AMA </option> <option data-style-url-name="apa" value="APA" > APA </option> <option data-style-url-name="mla" value="MLA" > MLA </option> <option data-style-url-name="nlm" value="NLM" selected="selected"> NLM </option> </select> </div> </li> </ul> </div> </div> </div> <div class="overlay" role="dialog" hidden> <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Add to Collections</h2> </div> <div class="collections-action-panel action-panel"> <form id="collections-action-dialog-form" class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/list-existing-collections/" data-add-to-existing-collection-url="/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/"> <input type="hidden" name="csrfmiddlewaretoken" value="HyACvMs37CaTiLeEkFECsfjMRRtRBqLKBAZsD6qnS10AP8f19AdbXAp54XrZtiTX"> <fieldset class="usa-fieldset margin-bottom-2"> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-new" class="usa-radio__input usa-radio__input--tile collections-new margin-top-0" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new" /> <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label> </div> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-existing" class="usa-radio__input usa-radio__input--tile collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing" /> <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label> </div> </fieldset> <fieldset class="usa-fieldset margin-bottom-2"> <div class="action-panel-control-wrap new-collections-controls"> <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0"> Name your collection <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr> </label> <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="usa-input collections-action-add-to-new" pattern="[^"&=<>/]*" title="The following characters are not allowed in the Name field: "&=<>/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection" required /> </div> <div class="action-panel-control-wrap existing-collections-controls"> <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0"> Choose a collection </label> <select id="collections-action-dialog-add-to-existing" class="usa-select collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'"> </select> <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message"> Unable to load your collection due to an error<br> <a href="#">Please try again</a> </div> </div> </fieldset> <div class="display-inline-flex"> <button class="usa-button margin-top-0 action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore data-ga-category="collections_button" data-ga-action="click" data-ga-label="add"> Add </button> <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel" aria-label="Close 'Add to Collections' panel" ref="linksrc=close_collections_panel" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel"> Cancel </button> </div> </form> </div> </div> </div> </div> </div> </div> <footer class="ncbi-footer ncbi-dark-background " > <div class="ncbi-footer__icon-section"> <div class="ncbi-footer__social-header"> Follow NCBI </div> <div class="grid-container ncbi-footer__ncbi-social-icons-container"> <a href="https://twitter.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="40" height="40" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span> </a> <a href="https://www.facebook.com/ncbi.nlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="16" height="29" focusable="false" aria-hidden="true" viewBox="0 0 16 29" fill="none" xmlns="http://www.w3.org/2000/svg"> <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z"> </path> </svg> <span class="usa-sr-only">NCBI on Facebook</span> </a> <a href="https://www.linkedin.com/company/ncbinlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="25" height="23" viewBox="0 0 26 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z"> </path> <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z"> </path> <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z"> </path> </svg> <span class="usa-sr-only">NCBI on LinkedIn</span> </a> <a href="https://github.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="28" height="27" viewBox="0 0 28 28" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z"> </path> </svg> <span class="usa-sr-only">NCBI on GitHub</span> </a> <a href="https://ncbiinsights.ncbi.nlm.nih.gov/" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="26" height="26" viewBox="0 0 27 27" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z"> </path> <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z"> </path> <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z"> </path> </svg> <span class="usa-sr-only">NCBI RSS feed</span> </a> </div> </div> <div data-testid="gridContainer" class="grid-container ncbi-footer__container"> <div class="grid-row ncbi-footer__main-content-container" data-testid="grid"> <div class="ncbi-footer__column"> <p class="ncbi-footer__circled-icons-heading"> Connect with NLM </p> <div class="ncbi-footer__circled-icons-list"> <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="32" height="32" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span> </a> <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="13" height="24" viewBox="0 0 13 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z"> </path> </svg> <span class="usa-sr-only">NLM on Facebook</span> </a> <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="21" height="15" viewBox="0 0 21 15" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z" fill="white" /> </svg> <span class="usa-sr-only">NLM on YouTube</span> </a> </div> </div> <address class="ncbi-footer__address ncbi-footer__column"> <p> <a class="usa-link usa-link--external" href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323" rel="noopener noreferrer" target="_blank">National Library of Medicine <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a> </p> </address> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link usa-link--alt ncbi-footer__link" > Web Policies </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link usa-link--alt ncbi-footer__link" > FOIA </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS Vulnerability Disclosure </a> </li> </ul> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://support.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > Help </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link usa-link--alt ncbi-footer__link" > Accessibility </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link usa-link--alt ncbi-footer__link" > Careers </a> </li> </ul> </div> <div class="grid-row grid-col-12" data-testid="grid"> <ul class="ncbi-footer__bottom-links-list"> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NLM </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NIH </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > USA.gov </a> </li> </ul> </div> </div> </footer> <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script> <button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top"> <label>Back to Top</label> <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#arrow_upward"></use> </svg> </button> <script src="https://code.jquery.com/jquery-3.5.0.min.js" integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ=" crossorigin="anonymous"> </script> <script type="text/javascript">var exports = {};</script> <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script> <script type="application/javascript"> window.ncbi = window.ncbi || {}; window.ncbi.pmc = window.ncbi.pmc || {}; window.ncbi.pmc.options = { logLevel: 'INFO', staticEndpoint: '/static/', citeCookieName: 'pmc-cf', }; </script> <script type="module" crossorigin="" src="/static/assets/base-9bea7450.js"></script> <script type="module" crossorigin="" src="/static/assets/article-722d91a2.js"></script> </body> </html>

CINXE.COM

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - PMC